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Abstract
Protein tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed phosphatase implicated in energy
balance regulation. CNS-specific PTP1B-deficiency results in a lean phenotype with resistance to diet-
induced obesity. PTP1B antagonizes actions of leptin, which regulates central energy balance by suppressing
food intake and elevating energy expenditure. Although the metabolic effects of PTP1B-deficiency have been
largely attributed to improved leptin sensitivity, mice lacking both leptin and PTP1B weigh less compared to
the mice lacking leptin only, suggesting leptin-independent metabolic effects of PTP1B-deficiency.
Biochemical studies have identified tropomyosin receptor kinase B (TrkB) as a potential substrate for PTP1B.
Since TrkB ligand brain-derived neurotrophic factor (BDNF) is a key player in energy balance, this
dissertation tests the hypothesis that PTP1B is a physiological regulator of central BDNF/TrkB signaling and
further examines the metabolic role of endogenous hypothalamic and hindbrain BDNF/TrkB signaling. To
assess whether PTP1B is a physiological regulator of central BDNF/TrkB signaling, an immortalized human
neuronal SH-SY5Y-TrkB cell line was utilized in biochemical studies in vitro, and a mouse model of global
PTP1B-deficiency (Ptpn1-/-) was used to test the metabolic response to exogenous central BDNF delivery in
vivo. In SH-SY5Y-TrkB cells, PTP1B overexpression and PTP1B inhibition impairs and augments TrkB
signaling, respectively. Furthermore, PTP1B interacts with the BDNF-activated TrkB receptor. Ptpn1-/- mice
exhibit enhanced hypothalamic TrkB phosphorylation, and are hypersensitive to central BDNF-induced
increase in core temperature. Whether Ptpn1-/- mice show increased hypothalamic neurogenesis was
explored through BrdU studies. To further elucidate the role of endogenous BDNF/TrkB signaling in central
metabolic control, hypothalamus (Nkx2.1-Ntrk2-/-) or hindbrain (Phox2b-Ntrk2+/-) specific TrkB-deficient
mice were generated and their metabolic phenotype was analyzed in comparison to wild type controls.
Nkx2.1-Ntrk2-/- mice display increased body weight and adiposity due to alterations in food intake and
energy expenditure, and have glucose homeostasis impairments. Interestingly, female mice lacking TrkB in the
hypothalamus have a more robust metabolic phenotype. Phox2b-Ntrk2+/- mice exhibit pronounced
hyperphagia despite the absence of a body weight phenotype. In summary, these data clearly establish PTP1B
as a novel, physiological regulator of central BDNF/TrkB signaling, and that endogenous hypothalamic and
hindbrain TrkB signaling are essential to central metabolic control.
Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Graduate Group
Neuroscience
First Advisor
Kendra K. Bence
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/1927
Subject Categories
Neuroscience and Neurobiology
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/1927
 REGIONAL ROLES OF CENTRAL TRKB RECEPTORS IN ENERGY BALANCE AND 
REGULATION BY PTP1B 
Ceren Ozek 
A DISSERTATION 
in 
Neuroscience 
Presented to the Faculties of the University of Pennsylvania 
in 
Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
2015 
 
 
Supervisor of Dissertation       
______________________      
Kendra K. Bence, Associate Professor of Biomedical Sciences     
   
Graduate Group Chairperson 
______________________ 
Joshua I. Gold, Professor of Neuroscience 
 
Dissertation Committee  
Robert G. Kalb (Chair), Professor of Neurology 
Harvey J. Grill, Professor of Psychology 
Bart C. DeJonghe, Assistant Professor of Biobehavioral and Health Sciences 
Teresa M. Reyes, Associate Professor of Psychiatry and Behavioral Neuroscience 
 
 
  
 
 
 
 
 
 
 
 
 
 
REGIONAL ROLES OF CENTRAL TRKB RECEPTORS IN ENERGY BALANCE AND 
REGULATION BY PTP1B 
COPYRIGHT 
2015 
Ceren Ozek 
 
iii 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
“It takes courage to grow up and become who you really are.” E.E. Cummings 
I dedicate this dissertation to my parents who have given me courage and provided full support to 
follow what I’ve been the most passionate about in life. 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
ACKNOWLEDGMENTS 
 
First and foremost, I would like to express my deepest gratitude to my advisor, Dr. Kendra 
Bence for supporting me during these past 5 years. Her remarkable mentorship 
throughout my graduate career at Penn has been invaluable. She has provided me with 
guidance and advice whenever I faced a scientific challenge. She has taught me scientific 
writing and presentation skills. She has also given me freedom to work independently, 
design my own experiments, the opportunity to present my work through poster and oral 
presentations as well as to pursue a vast number of extracurricular opportunities our 
graduate program offers. Without her support and leadership, this dissertation would not 
have been possible.  
 
I would also like to thank my thesis committee members: Drs Bob Kalb, Harvey Grill, Bart 
DeJonghe and Teresa Reyes for guiding my research, providing scientific expertise and 
direction throughout my graduate career. They have been very motivating, encouraging, 
and insightful. They have made thesis committee meetings an event to look forward to.  
 
My gratitude also extends to the Neuroscience Graduate Group (NGG) that I call my 
second home. With its chairs: Mikey Nusbaum, Rita Balice-Gordon and Josh Gold, 
coordinators: Jane Hoshi and Christine Clay, all its graduate students and Graduate-Led 
Initiatives and Activities (GLIA) that I’ve been proud to be a part of since its conception, it 
has been an extremely supportive, accepting and positive environment to be in for my 
doctoral training. 
 
Next, I would like to thank all the past and present Bence lab members and in particular 
Derek Zimmer, Ryan Tsou, Kimberly Rak, and Helen Liu not only for their technical 
v 
 
assistance with experiments but also their friendship. It has been an absolute pleasure to 
work alongside them as well as to share exciting and frustrating moments during my 
graduate career.   
 
Last but certainly not least, I would like to give a heartfelt thanks to my parents, Drs Memet 
and Eren Ozek, and my fiancé, Brian Moore, for believing in me throughout this long and 
mentally challenging journey even during times when I doubted myself. They have been 
a constant source of love, care, patience, generosity, and strength. There are simply no 
words to convey how much I love them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vi 
 
ABSTRACT 
 
REGIONAL ROLES OF CENTRAL TRKB RECEPTORS IN ENERGY BALANCE AND 
REGULATION BY PTP1B 
Ceren Ozek 
Kendra K. Bence 
 
Protein tyrosine phosphatase 1B (PTP1B) is a ubiquitously expressed phosphatase 
implicated in energy balance regulation. CNS-specific PTP1B-deficiency results in a lean 
phenotype with resistance to diet-induced obesity. PTP1B antagonizes actions of leptin, 
which regulates central energy balance by suppressing food intake and elevating energy 
expenditure. Although the metabolic effects of PTP1B-deficiency have been largely 
attributed to improved leptin sensitivity, mice lacking both leptin and PTP1B weigh less 
compared to the mice lacking leptin only, suggesting leptin-independent metabolic effects 
of PTP1B-deficiency. Biochemical studies have identified tropomyosin receptor kinase B 
(TrkB) as a potential substrate for PTP1B. Since TrkB ligand brain-derived neurotrophic 
factor (BDNF) is a key player in energy balance, this dissertation tests the hypothesis that 
PTP1B is a physiological regulator of central BDNF/TrkB signaling and further examines 
the metabolic role of endogenous hypothalamic and hindbrain BDNF/TrkB signaling. To 
assess whether PTP1B is a physiological regulator of central BDNF/TrkB signaling, an 
immortalized human neuronal SH-SY5Y-TrkB cell line was utilized in biochemical studies 
in vitro, and a mouse model of global PTP1B-deficiency (Ptpn1-/-) was used to test the 
metabolic response to exogenous central BDNF delivery in vivo. In SH-SY5Y-TrkB cells, 
PTP1B overexpression and PTP1B inhibition impairs and augments TrkB signaling, 
respectively. Furthermore, PTP1B interacts with the BDNF-activated TrkB receptor. 
Ptpn1-/- mice exhibit enhanced hypothalamic TrkB phosphorylation, and are 
vii 
 
hypersensitive to central BDNF-induced increase in core temperature. Whether Ptpn1-/- 
mice show increased hypothalamic neurogenesis was explored through BrdU studies. To 
further elucidate the role of endogenous BDNF/TrkB signaling in central metabolic control, 
hypothalamus (Nkx2.1-Ntrk2-/-) or hindbrain (Phox2b-Ntrk2+/-) specific TrkB-deficient 
mice were generated and their metabolic phenotype was analyzed in comparison to wild 
type controls. Nkx2.1-Ntrk2-/- mice display increased body weight and adiposity due to 
alterations in food intake and energy expenditure, and have glucose homeostasis 
impairments. Interestingly, female mice lacking TrkB in the hypothalamus have a more 
robust metabolic phenotype. Phox2b-Ntrk2+/- mice exhibit pronounced hyperphagia 
despite the absence of a body weight phenotype. In summary, these data clearly establish 
PTP1B as a novel, physiological regulator of central BDNF/TrkB signaling, and that 
endogenous hypothalamic and hindbrain TrkB signaling are essential to central metabolic 
control.  
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CHAPTER 1: Introduction 
 
Obesity is a highly prevalent health problem within the United States. According to the 
2011-2012 National Health and Nutrition Examination Survey, approximately 70% of the 
U.S. population is classified as overweight (Body Mass Index, BMI≥25) or obese 
(BMI≥30). Notably, childhood obesity in the U.S. population is approximately 30% (Ogden, 
Carroll et al. 2014). Obesity is associated with co-morbidities including type 2 diabetes, 
hypertension, cardiovascular diseases and cancer (reviewed in (Ahima 2011)). Obesity 
imposes a serious health and economic burden on the society and unfortunately there are 
no effective, long-term treatments available. Consequently, understanding the biological 
mechanisms contributing to the regulation of body weight is essential in developing safe 
and more efficient therapies to treat obesity.  
 
Recent human genome-wide association studies (GWAS) highlight the role of the central 
nervous system (CNS) in the regulation of energy balance and the increased 
predisposition to obesity (Speliotes, Willer et al. 2010, Locke, Kahali et al. 2015). The 
hypothalamus and the hindbrain are two key brain regions that sense the circulating 
metabolic signals from the periphery. Neurons in the hypothalamus and the hindbrain 
integrate and relay these signals to downstream nuclei and to higher brain regions to effect 
physiological changes to maintain energy homeostasis (reviewed in (Coll and Yeo 2013)).  
 
The melanocortin system in the hypothalamus and the hindbrain is a well-established 
contributor to the central regulation of energy balance (see Figure 1). The melanocortin 
circuit is comprised of two distinct sub-populations of neurons: pro-opiomelanocortin 
(POMC) / cocaine and amphetamine regulated transcript (CART)-expressing 
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anorexigenic neurons, and agouti-related peptide (AGRP) / neuropeptide Y (NPY)-
expressing orexigenic neurons. Upon activation of POMC+ neurons, the POMC precursor 
peptide is cleaved to produce biologically active alpha-melanocyte-stimulating hormone 
(α-MSH) which is an endogenous ligand for the melanocortin 3 and 4 receptors (MC3R 
and MC4R). Upon activation of AGRP+ neurons, AGRP peptide is released which acts as 
an antagonist by competing for MCR binding and inhibiting receptor activation (reviewed 
in (Schwartz, Woods et al. 2000)).  
 
Within the hypothalamus, the arcuate nucleus (ARC) has two distinct populations of 
POMC/CART+ and AGRP/NPY+ neurons which form the “first-order neurons” of the 
melanocortin system. Circulating hormones such as leptin or insulin stimulate POMC+ 
neurons and inhibit AGRP+ neurons simultaneously in the ARC to suppress food intake 
and increase energy expenditure. AGRP neurons inhibit POMC neurons in the ARC 
through gamma-aminobutyric acid (GABA) release (Cowley, Smart et al. 2001). These 
first-order neurons subsequently send projections to other hypothalamic nuclei to regulate 
energy balance. POMC+ and AGRP+ neurons in the ARC project to the downstream 
“second-order neurons” such as the paraventricular nucleus of the hypothalamus (PVH) 
and lateral hypothalamus (LH) (Elias, Saper et al. 1998, Elmquist, Ahima et al. 1998). 
Within the PVH, there are different sub-types of neurons which suppress food intake 
including corticotropin-releasing hormone (CRH)-expressing neurons which also activate 
the sympathetic nervous system, thyrotropin-releasing hormone (TRH)-expressing 
neurons which stimulate the thyroid axis, and oxytocin-expressing neurons which regulate 
uterine function. Within the LH, melanin-concentrating hormone (MCH)-expressing and 
orexin-expressing neurons promote hyperphagia. POMC+ and AGRP+ neurons also have 
synaptic connections with the ventromedial (VMH) and dorsomedial (DMH) nuclei of the 
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hypothalamus to suppress or promote feeding, respectively (Elmquist, Ahima et al. 1998). 
Taken together, hypothalamic MC4R signaling plays a paramount role in energy balance 
regulation (reviewed in (Schwartz, Woods et al. 2000, Saper, Chou et al. 2002, Konturek, 
Konturek et al. 2005, De Jonghe, Hayes et al. 2011)).   
 
In addition to the ARC of the hypothalamus, POMC+ neurons also exist in the nucleus 
tractus solitarius (NTS, or nucleus of the solitary tract) of the hindbrain. In fact, these two 
brain regions are the only regions where POMC+ neurons exist. These POMC+ neurons 
along with the POMC+ neurons in the ARC release α-MSH to the MC4R+ neurons in the 
caudal brainstem to regulate energy balance (Skibicka and Grill 2009, Zheng, Patterson 
et al. 2010). Dorsal vagal complex (DVC) including the dorsal motor nucleus of the vagus 
nerve is the site with the highest MC4R expression in the brainstem. Exogenous MC4R 
agonist administration into the DVC significantly suppresses food intake (Williams, Kaplan 
et al. 2000).  Neurons in the NTS also receive input from the PVH and the LH. In turn, they 
send projections to the hypothalamus directly and indirectly, through parabrachial nucleus 
(PBN) (Ricardo and Koh 1978, Shah, Vong et al. 2014). Taken together, hindbrain MC4R 
signaling is also essential in energy balance regulation.  (reviewed in (Schwartz, Woods 
et al. 2000, Saper, Chou et al. 2002, Konturek, Konturek et al. 2005, De Jonghe, Hayes 
et al. 2011, Grill and Hayes 2012)).   
 
There are numerous signaling pathways within the cell types outlined above that 
contribute to the central control of body weight and dysregulation of these signaling 
pathways can lead to obesity. Reversible phosphorylation of target proteins is a key 
regulatory mechanism utilized in cellular signaling. Phosphorylation status of signaling 
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molecules determines their enzymatic activity, subcellular localization and their 
interactions with other molecules. Reversible phosphorylation at serine, threonine or 
tyrosine residues is regulated through the opposing actions of kinases and phosphatases. 
Protein tyrosine phosphatases (PTPs) regulate signal transduction by dephosphorylating 
the phosphorylated tyrosine residues and act as critical negative or positive regulators of 
signaling pathways. Understanding the role of PTPs in the central regulation of energy 
balance is essential since targeting PTPs can sensitize pathways that are disrupted in 
obesity (reviewed in (Zhang and Zhang 2007)).   
 
PTP1B plays an important role in energy balance regulation  
In the PTP superfamily, there are 107 different genes (Alonso, Sasin et al. 2004). PTPs 
are defined by their active site signature motif HCX5R, in which the conserved cysteine 
residue acts as a nucleophile that is essential for catalytic activity. Despite the conserved 
active site motif, structural diversity within the PTP family is achieved through different 
domains and allows substrate specificity and functional diversity (reviewed in (Tonks 2006, 
Li, Wilmanns et al. 2013)).  
 
One of the best characterized PTPs is PTP1B. PTP1B is a ubiquitously expressed protein 
tyrosine phosphatase encoded by the gene PTPN1 located on human chromosome 20q13 
(Brown-Shimer, Johnson et al. 1990). A number of studies have revealed single nucleotide 
polymorphisms in the PTPN1 gene to be associated with obesity, type 2 diabetes, lipid 
abnormalities, insulin resistance, and increased cardiovascular disease risk in different 
human populations, making PTP1B a key player in metabolic dysfunction (reviewed in 
(Tsou and Bence 2012)). PTP1B, isolated from human placenta and found to be ~50kDa 
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at full-length, was the first PTP to be purified (Tonks, Diltz et al. 1988, Chernoff, Schievella 
et al. 1990) and to have its crystal structure resolved (Barford, Flint et al. 1994, Jia, Barford 
et al. 1995). PTP1B is an endoplasmic reticulum-bound protein due to hydrophobic amino 
acid residues in the C-terminus, but proteolytic cleavage generates a more active, soluble 
form (Frangioni, Beahm et al. 1992, Frangioni, Oda et al. 1993). Early in vitro studies 
reported that PTP1B injection into Xenopus oocytes blocks insulin-stimulated tyrosine 
phosphorylation (Cicirelli, Tonks et al. 1990). Both insulin and insulin-like growth factor 1 
(IGF-1) increase PTP1B activity and PTP1B negatively regulates insulin signaling 
(Kenner, Hill et al. 1993, Kenner, Anyanwu et al. 1996). Generation of substrate-trapping 
mutants through the use of site-directed mutagenesis (Flint, Tiganis et al. 1997) led to the 
discovery that (E/D)-pY-pY-(R/K) is the preferred consensus substrate recognition motif 
for PTP1B (Salmeen, Andersen et al. 2000). Biochemical studies have reported that 
PTP1B binds to and dephosphorylates multiple substrates with this conserved recognition 
motif, including the insulin receptor (IR) (Salmeen, Andersen et al. 2000), insulin-like 
growth factor receptor (IGF1R) (Kenner, Anyanwu et al. 1996), Janus kinase 2 (JAK2) and 
tyrosine kinase 2 (TYK2) kinases (Myers, Andersen et al. 2001), epidermal growth factor 
receptor (EGFR) (Flint, Tiganis et al. 1997), and platelet-derived growth factor receptor 
(PDGFR) (Liu and Chernoff 1997).  
 
Generation of PTP1B-deficient mice has played a crucial role in determining the role of 
PTP1B in energy balance regulation, mostly through PTP1B’s effects on leptin and insulin 
signaling. Mice with global PTP1B-deficiency (Ptpn1-/-) show increased insulin sensitivity 
through enhanced and/or prolonged activation of insulin signaling and resistance to high-
fat diet (HFD)-induced obesity compared to wild type controls (Elchebly, Payette et al. 
1999). In a separate study with another mouse line of global PTP1B-deficiency, Ptpn1-/- 
mice show decreased adiposity in addition to reduced body weight. In this study, Ptpn1-/- 
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mice show increased basal metabolic rate and total energy expenditure to partly explain 
the lean body weight phenotype (Klaman, Boss et al. 2000). The generation of tissue-
specific PTP1B-deficient mouse lines has helped to clarify the organ/tissue/cell-type-
specific roles for PTP1B in metabolism. Mice with brain-specific PTP1B-deficiency 
(Nestin-Cre-Ptpn1-/-) exhibit reduced body weight and adiposity on both chow diet and 
HFD. These mice display both reduced food intake and increased energy expenditure. 
Furthermore, they are leptin and insulin hypersensitive (Bence, Delibegovic et al. 2006). 
These results suggest that central PTP1B-deficiency recapitulates the metabolic 
phenotype of global PTP1B-deficiency, and central PTP1B plays a key role in the 
regulation of body weight and glucose homeostasis. Recently, mouse models with more 
restricted deletion of PTP1B in the brain have been generated. Deletion of PTP1B only in 
POMC neurons (POMC-Cre-Ptpn1-/-) results in a lean phenotype with resistance to diet-
induced obesity, primarily due to increased energy expenditure. Notably, POMC-Ptpn1-/- 
mice have a heightened cold-induced thermogenic response (De Jonghe, Hayes et al. 
2011). These mice also display leptin and insulin hypersensitivity (Tsou, Zimmer et al. 
2012, Dodd, Decherf et al. 2015). Deletion of PTP1B in leptin receptor-expressing neurons 
(LepRb-Cre-Ptpn1-/-) results in reduced body weight and adiposity along with leptin 
hypersensitivity (Tsou, Zimmer et al. 2012). Hypothalamus-specific PTP1B-deficient mice 
(Nkx2.1-Cre-Ptpn1-/-) have reduced body weight and adiposity with no improvement in 
glucose homeostasis (Tsou, Rak et al. 2014). Interestingly, mice with VMH-specific 
PTP1B-deficiency (Sf1-Cre-Ptpn1-/-) show an age-dependent increase in body weight 
and adiposity (Chiappini, Catalano et al. 2014). These studies suggest that PTP1B 
regulation of energy balance in the brain is complicated and likely involves different 
neuronal sub-populations and different brain regions.  
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PTP1B-deficiency in the periphery, unlike PTP1B-deficiency in the CNS, does not result 
in a lean body weight phenotype. PTP1B deletion in the liver (Albumin-Cre-Ptpn1-/-) or in 
the skeletal muscle (MCK-Cre-Ptpn1-/-) improves glucose homeostasis, lipid metabolism 
and insulin sensitivity, independent of changes in body weight and adiposity (Bence, 
Delibegovic et al. 2006, Delibegovic, Bence et al. 2007, Delibegovic, Zimmer et al. 2009). 
Taken together, these findings indicate that PTP1B is a negative regulator of insulin 
signaling in insulin-responsive tissues, and insulin-sensitizing effects of PTP1B-deficiency 
may be mediated by liver and/or skeletal muscle. Interestingly, adipocyte-specific PTP1B 
deletion (Adiponectin-Cre-Ptpn1-/-) has no effect on body weight and adiposity but 
increases adipocyte size, circulating glucose and leptin levels and impairs leptin 
sensitivity. PTP1B-deficiency in the adipocytes does not influence glucose homeostasis 
or insulin sensitivity, suggesting that PTP1B is not a major regulator of insulin signaling in 
this tissue (Owen, Czopek et al. 2012).  
 
PTP1B is a negative regulator of leptin signaling 
Perhaps one of the best studied targets of PTP1B is leptin signaling, an important 
regulator of energy balance. Mice lacking leptin (ob/ob) or its receptor, LepRb (db/db), are 
obese due to increased food intake and reduced energy expenditure (Friedman and 
Halaas 1998). Serum leptin levels are associated with increased BMI and adipose tissue 
weight; obese humans have significantly higher leptin levels than the control subjects and 
weight loss results in a dramatic decrease in plasma leptin levels (Maffei, Halaas et al. 
1995). Notably, peripheral or central leptin administration reduces body weight and food 
intake in ob/ob and diet-induced obese (DIO) mice, suggesting that central leptin signaling 
plays an important role in energy balance regulation (Campfield, Smith et al. 1995, Halaas, 
Boozer et al. 1997).    
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Leptin is a 16kDa protein secreted from adipose tissue. Cloning of the mouse obese (ob) 
gene led to its discovery in the 1990s (Zhang, Proenca et al. 1994). Leptin binds to its 
receptor, LepRb and activates the LepRb-associated tyrosine kinase, JAK2. JAK2 
promotes tyrosine phosphorylation of three sites (namely Y985, Y1077, and Y1138) on 
the intracellular tail of LepRb, each mediating distinct arms of the leptin signaling pathway 
(Banks, Davis et al. 2000). Of these three sites, Y1138 phosphorylation recruits the 
transcription factor signal transducer and activator of transcription 3 (STAT3) which 
mediates the majority of leptin’s effects on energy homeostasis (Bates, Stearns et al. 
2003).  
 
PTP1B regulates the leptin signaling pathway in vitro by binding to and dephosphorylating 
JAK2 (Myers, Andersen et al. 2001, Cheng, Uetani et al. 2002). Further studies in vivo 
reported that PTP1B negatively regulates leptin signaling by directly dephosphorylating 
JAK2; PTP1B overexpression in cell lines dose-dependently diminishes leptin-induced 
phosphorylation of JAK2 and STAT3, and Ptpn1-/- mice display increased sensitivity to 
leptin-induced suppression of food intake and body weight (Cheng, Uetani et al. 2002, 
Zabolotny, Bence-Hanulec et al. 2002). HFD-induced hyperleptinemia is also associated 
with significantly increased PTP1B levels, which is thought to contribute to the 
development of leptin resistance (Morrison, White et al. 2007, White, Whittington et al. 
2009).  
 
Despite compelling evidence that PTP1B’s role in regulating energy balance is 
predominantly through its interaction with leptin signaling, whether the metabolic effects 
of PTP1B-deficiency are exclusively due to sensitized leptin signaling has been under 
investigation. Interestingly, mice with compound deletion of leptin and PTP1B (ob/ob; 
Ptpn1-/-) display a leaner body weight phenotype and increased basal metabolic rate 
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compared to leptin-deficient (ob/ob) mice, suggesting that PTP1B-deficiency may have 
leptin-independent effects (Cheng, Uetani et al. 2002). Since ob/ob;Ptpn1-/- mice still 
express LepRb, the observed phenotype may be due to ligand-independent activation of 
the leptin receptor. Furthermore, compound deletion of leptin receptor and PTP1B 
(db/db;Ptpn1-/-) reduces serum triglyceride and free fatty acids (Ali, Ketsawatsomkron et 
al. 2009). Notably, deletion of PTP1B in leptin receptor-expressing cells (LepRb-Cre-
Ptpn1-/-) results in a reduction in body weight and adiposity comparable to global PTP1B-
deficiency, suggesting that deletion of PTP1B in leptin receptor-expressing cells likely 
underlies majority of the metabolic phenotypes of PTP1B-deficiency. However, subtle 
metabolic differences exist between LepRb-Ptpn1-/- and Ptpn1-/- mice (such as reduced 
adiposity phenotype limited to Ptpn1-/- mice on chow diet and difference in the onset of 
body weight phenotype between LepRb-Ptpn1-/- and Ptpn1-/- mice on HFD (Tsou, 
Zimmer et al. 2012). In hypothalamic-PTP1B-deficiency, LepRb does appear to be 
required to mediate the beneficial metabolic effects of a lack of PTP1B. Whether leptin 
signaling interacts with additional downstream pathways in the hypothalamus, and/or 
whether PTP1B-deficiency in the LepRb+ neurons in the extra-hypothalamic areas 
engage additional signaling pathways is unclear.  
 
BDNF/TrkB neurotrophic signaling is a potential target of PTP1B 
Another important regulator of energy balance in addition to leptin is the brain-derived 
neurotrophic factor (BDNF) with its receptor tropomyosin receptor kinase B (TrkB). There 
is ample evidence implicating BDNF/TrkB signaling as relevant to obesity pathogenesis in 
humans. Recent human genome-wide association studies link single nucleotide 
polymorphisms within the BDNF gene with increased BMI (Speliotes, Willer et al. 2010, 
Locke, Kahali et al. 2015). One of these variants changes the valine residue at position 66 
to a methionine residue, resulting in impaired BDNF secretion through the activity-
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dependent secretory pathway (Beckers, Peeters et al. 2008). Loss of one copy of the 
BDNF gene resulting in BDNF haplo-insufficiency, or a de novo missense mutation in the 
Y722 active site tyrosine residue of TrkB resulting in a kinase-dead TrkB receptor, are 
both associated with obesity and hyperphagia (Yeo, Connie Hung et al. 2004, Gray, Yeo 
et al. 2006, Han, Liu et al. 2008).   
 
Neurotrophins are a family of proteins initially discovered for their role in the survival of 
different neuronal sub-populations. The first neurotrophin, nerve growth factor (NGF) was 
discovered in the 1950s as a survival factor for sensory and sympathetic neurons (Levi-
Montalcini and Hamburger 1951). The second neurotrophin, BDNF was isolated from the 
pig brain in the 1980s as a survival factor for a sub-population of neurons unresponsive to 
NGF (Barde, Edgar et al. 1982). Since then, other neurotrophic factors including 
neurotrophin-3 (NT-3) (Maisonpierre, Belluscio et al. 1990) and neurotrophin 4/5 (NT-4/5)  
(Hallbook, Ibanez et al. 1991, Ip, Ibanez et al. 1992) have been identified. Each 
neurotrophin has distinct effects on sub-populations of neurons in the CNS and peripheral 
nervous system (PNS). Neurotrophins regulate neuronal growth, survival and 
differentiation, axonal and dendritic growth and guidance, neurotransmitter release, 
synapse formation, synaptic plasticity and long-term potentiation during development and 
in adulthood (reviewed in (Chao 2003, Reichardt 2006)).  
 
Each neurotrophin preferentially binds to one or more of the Trk family of proteins 
(reviewed in (Patapoutian and Reichardt 2001)). TrkA binds NGF, TrkB binds BDNF and 
NT4/5, TrkC binds NT-3. Neurotrophin binding leads to ligand-induced dimerization and 
autophosphorylation of the several tyrosine residues on the intracellular tail of the Trk 
receptors, creating specific binding sites for adaptor proteins, and leading to distinct 
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intracellular signaling cascades including rat sarcoma (Ras)/mitogen activated protein 
kinase (MAPK) signaling, phosphoinositide 3-kinase (PI3K) signaling, and phospholipase 
C-gamma (PLC-γ) signaling (reviewed in (Barbacid 1994, Patapoutian and Reichardt 
2001, Segal 2003)). Each neurotrophin also binds to low affinity p75 receptor (p75NTR) 
which has a short cytoplasmic tail that lacks intrinsic catalytic activity. p75NTR binding leads 
to intracellular signaling cascades including nuclear factor-kappa-b (NF-κB) and jun kinase 
signaling that are distinct from those activated by the Trk receptors (reviewed in (Dechant 
and Barde 2002)).   
 
BDNF is encoded by the human BDNF gene located on human chromosome 11p13 
(Maisonpierre, Le Beau et al. 1991). BDNF gene has nine exons, eight of which form the 
5’ untranslated region (5’UTR) and exon IX which contains the entire coding sequence 
and the 3’ untranslated region (3’UTR). Alternative splicing leads to mRNA transcripts with 
the same coding exon but with different 5’UTRs (containing one of I, II, III, or IV non-coding 
exons) and polyadenylation sites. Although the various transcripts code for the same 
protein, each transcript has distinct spatial, temporal, and activity-dependent expression 
patterns. Furthermore, there are specific post-transcriptional modifications which affect 
mRNA stability and translation of transcripts, resulting in fine-tuned regulation of BDNF 
synthesis (reviewed in (Timmusk, Palm et al. 1993, Aid, Kazantseva et al. 2007)). BDNF 
is initially synthesized as the pre-pro-BDNF, cleaved in the endoplasmic reticulum to form 
the 32kDa pro-BDNF that is further cleaved in the Golgi apparatus to form the 14 kDa 
mature BDNF (Mowla, Farhadi et al. 2001). Both pro-BDNF and mature BDNF can be 
secreted through activity-dependent secretory pathway. Both pro-BDNF and mature 
BDNF are biologically active; pro-BDNF binds p75NTR to induce apoptosis and long-term 
depression while mature BDNF binds TrkB to promote cell survival and long-term 
potentiation (Teng, Teng et al. 2005, Mizui, Ishikawa et al. 2015).      
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TrkB is encoded by the human NTRK2 gene located on human chromosome 9q22 
(Nakagawara, Liu et al. 1995). NTRK2 gene has 24 exons, the first five exons of which 
serve as potential transcriptional start sites. Through alternative promoters, splicing 
patterns and polyadenylation sites, NTRK2 gene can generate 100 different isoforms and 
10 different proteins (Stoilov, Castren et al. 2002). Human full-length TrkB (TrkB.FL) codes 
for an 822 amino acid protein. There are two additional truncated TrkB isoforms, namely 
TrkB.T1 (using exon 16) and TrkB.Shc (using exon 19), both of which lack the tyrosine 
kinase domain encoded by exons 20-24 and thus act as dominant negative inhibitors of 
TrkB.FL. These truncated TrkB isoforms have distinct intracellular signaling pathways that 
are not activated by the full-length TrkB receptor (reviewed in (Brodeur, Minturn et al. 
2009)). 
 
BDNF homodimers bind to and autophosphorylate the TrkB receptor at five cytoplasmic 
tyrosine residues (namely Y516, Y702, Y706, Y707, Y817). Of these, Y702, Y706, and 
Y707 tyrosine residues are the active site tyrosine residues within the tyrosine kinase 
domain of the TrkB receptor. Phosphorylation of Y516 recruits Src-homology 2 domain 
containing (Shc) adaptor protein which activates Ras/extracellular signal-regulated kinase 
(Erk) and PI3-K/protein kinase B (Akt) signaling pathways. These pathways activate 
mammalian target of rapamycin (mTOR) signaling and also lead to transcription factor 
cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) 
phosphorylation. Phosphorylation of Y817 recruits PLC-γ which increases the intracellular 
Ca+2 levels leading to activation of calcium-calmodulin kinase 2 (CaMKII) and CREB 
(reviewed in (Patapoutian and Reichardt 2001, Minichiello, Calella et al. 2002, Reichardt 
2006, Cunha, Brambilla et al. 2010)).  
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Interestingly, PTP1B-specific substrate recognition motif ((E/D)-pY-pY-(R/K)), found in all 
known substrates for PTP1B, is also present in the tyrosine kinase domain of the TrkB 
receptor, making TrkB a potential substrate for PTP1B (Espanel, Huguenin-Reggiani et 
al. 2002). 
 
BDNF/TrkB signaling plays a key role in energy balance regulation 
BDNF is broadly expressed throughout the developing and adult CNS. BDNF mRNA is 
detected in the rat brain including cortex, hippocampus, ventral tegmental area (VTA), 
PVH, DMH, VMH, LH, NTS, substantia nigra, and amygdala. Furthermore, BDNF-
immunoreactive fibers are detected in the rat brain including the ARC, dorsal raphe 
nucleus, bed nucleus of the stria terminalis, central habenula, and nucleus accumbens 
(NAc) in the absence of BDNF mRNA suggesting anterograde axonal transport by afferent 
systems (Conner, Lauterborn et al. 1997, Yan, Rosenfeld et al. 1997). TrkB is also broadly 
expressed in the CNS throughout development and in adulthood. TrkB mRNA and protein 
are detected in the rat brain including the cortex, hippocampus, striatum, thalamus, 
hypothalamus (including VMH, DMH, PVH, LH, and ARC), amygdala, olfactory system, 
cerebellum, and brainstem (Masana, Wanaka et al. 1993, Yan, Radeke et al. 1997). Both 
BDNF and TrkB are detected in the PNS including the dorsal root ganglion (DRG) and the 
spinal cord. There are also reports that BDNF is present in the human non-neuronal 
tissues such as muscle, liver, lung, heart, and spleen (Yamamoto, Sobue et al. 1996, 
Noble, Billington et al. 2011).  
 
Earlier studies reported that exogenous BDNF administration regulates body weight, food 
intake and energy expenditure in rodents. Intracerebroventricular (i.c.v.) BDNF 
administration suppresses food intake and reduces body weight in rats (Pelleymounter, 
Cullen et al. 1995). In db/db mice, i.c.v. BDNF administration enhances thermogenesis, 
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induces norepinephrine turnover, and increases uncoupling protein 1 (Ucp1) expression, 
implicating a regulatory role for BDNF in energy expenditure via the activation of the 
sympathetic nervous system. Central BDNF administration also reduces food intake and 
improves glucose homeostasis in db/db mice (Nonomura, Tsuchida et al. 2001, Tsuchida, 
Nonomura et al. 2001). Peripheral BDNF administration improves glucose homeostasis in 
db/db and DIO mice by lowering blood glucose and restoring normal insulin levels (Tonra, 
Ono et al. 1999, Nakagawa, Tsuchida et al. 2000, Ono, Itakura et al. 2000, Nakagawa, 
Ono-Kishino et al. 2002, Tsuchida, Nonomura et al. 2002, Nakagawa, Ogawa et al. 2003).   
 
BDNF and TrkB are essential for many aspects of neural development. Thus, BDNF- or 
TrkB-null mice have an early postnatal lethal phenotype (Klein, Smeyne et al. 1993, 
Ernfors, Lee et al. 1994). BDNF heterozygous mice (Bdnf+/-) display increased body 
weight, increased adiposity due to adipose cell hypertrophy, and severe hyperphagia. 
These mice also show high serum leptin and insulin levels compared to controls (Lyons, 
Mamounas et al. 1999, Kernie, Liebl et al. 2000). Conditional deletion of BDNF in the adult 
mouse brain (CaMKII-Cre-Bdnf-/-) results in obesity, hyperphagia, high blood glucose, 
increased serum leptin and insulin levels (Rios, Fan et al. 2001). Insertion of TrkB cDNA 
into the first coding exon of the TrkB locus results in the generation of TrkB hypomorphic 
mice (fBZ/fBZ) with TrkB expression at a quarter of the normal amount. Similar to BDNF 
mouse models, these mice also exhibit increased body weight and hyperphagia (Xu, 
Goulding et al. 2003). All these studies point towards an important role of central 
BDNF/TrkB signaling in energy balance regulation. 
 
BDNF and TrkB are both expressed in the hypothalamus and the hindbrain, two brain 
regions known to play key roles in energy homeostasis through integrating acute and long-
term peripheral signals and regulating food intake and energy utilization in response. 
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Deletion of TrkB in several hypothalamic nuclei including the ARC, DMH, and LH with 
additional deletion in the striatum, hippocampus and cortex (Rgs9-Cre-Ntrk2-/-) results in 
increased body weight and hyperphagia (Liao, Li et al. 2013). However, in this model PVH 
and VMH are not targeted efficiently. Within the hypothalamus, the PVH is one of the 
nuclei where BDNF’s role in energy balance regulation has been examined. Deletion of 
BDNF constitutively (Sim1-Cre-Bdnf-/-) or in the adult PVH through AAV-Cre delivery 
results in an obese phenotype with increased adiposity, hyperphagia, reduced energy 
expenditure (through reduced activity and impaired adaptive thermogenesis), and 
impaired glucose homeostasis in mice (An, Liao et al. 2015). Moreover, direct BDNF 
administration into the PVH suppresses food deprivation- or NPY-induced food intake and 
reduces body weight in rats on chow diet and HFD (Wang, Bomberg et al. 2007, Wang, 
Godar et al. 2010). Orexigenic AGRP neurons in the ARC receive strong excitatory input 
from the PVH, and BDNF/TrkB signaling may likely contribute to the inhibition of this 
circuitry (Krashes, Shah et al. 2014). In rats, direct BDNF administration into the PVH 
increases energy expenditure through enhanced basal metabolic rate and enhanced 
thermogenesis, suggesting increased sympathetic tone (Wang, Bomberg et al. 2007). 
BDNF’s effects on food intake and energy expenditure in the PVH may be through CRH- 
and urocortin-expressing neurons. In the PVH, TrkB is co-expressed with some of the 
CRH+ neurons. i.c.v. BDNF administration into the lateral ventricle up-regulates Crh and 
urocortin gene expression in the PVH. Furthermore, activation of CRH+ neurons in the 
PVH reduces food intake and increases energy expenditure through increased 
sympathetic activity. Notably, BDNF’s effects on body weight are counteracted by the co-
administration of CRH and urocortin antagonists (Toriya, Maekawa et al. 2010).  
 
VMH is another hypothalamic nucleus where BDNF’s role in central metabolic control has 
been emphasized. In the VMH, BDNF gene expression is regulated by nutritional status. 
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Deletion of the BDNF gene in the adult VMH through AAV-Cre delivery results in an obese 
phenotype, hyperphagia, impaired glucose homeostasis yet normal energy expenditure 
(Unger, Calderon et al. 2007). Moreover, direct BDNF administration into the VMH 
suppresses food deprivation- and NPY-induced food intake and reduces body weight in 
chow diet- or HFD-fed rats (Wang, Bomberg et al. 2007, Godar, Dai et al. 2011). 
Anorexigenic POMC neurons in the ARC receive strong excitatory input from the VMH, 
and BDNF/TrkB signaling may likely contribute to the activation of this circuitry (Sternson, 
Shepherd et al. 2005). In rats, direct BDNF administration into the VMH increases energy 
expenditure through increased spontaneous physical activity, suggesting a distinct 
mechanism from that in the PVH (Wang, Bomberg et al. 2010).  BDNF’s effects on food 
intake and energy expenditure in the VMH may originate from steroidogenic factor 1 (Sf-
1). Within the VMH, a subset of neurons co-express BDNF and Sf-1. Furthermore, Sf-1 
induces BDNF gene expression in the VMH, and Sf1+/- mice show reduced BDNF mRNA 
in the VMH along with an obese phenotype and hyperphagia (Tran, Akana et al. 2006). 
Within the VMH, leptin administration also enhances BDNF mRNA and protein levels, and 
BDNF is necessary to convey leptin’s signal to activate hypothalamic neurons and to 
inhibit food intake (Komori, Morikawa et al. 2006, Liao, An et al. 2012). Leptin-induced 
activation of POMC neurons in the ARC results in the secretion of α-MSH to the VMH, 
where α-MSH binds MC4R and initiates the melanocortin signaling pathway (Noble, 
Billington et al. 2011). An MCR agonist, MTII, induces BDNF gene expression in the VMH. 
Notably, in Mc4r-/- mice and agouti-yellow mutant (Ay) mice, BDNF gene expression is 
reduced and BDNF administration into the VMH reduces body weight and food intake in 
these mice, suggesting that BDNF/TrkB signaling acts downstream of melanocortin 
signaling in the VMH (Xu, Goulding et al. 2003).  
 
17 
 
Within the hindbrain, the dorsal vagal complex (DVC) has been implicated in mediating 
BDNF’s role in energy balance regulation. BDNF administration into the DVC reduces 
body weight and food intake in rats, and BDNF gene expression in the DVC is regulated 
by nutritional status and leptin (Bariohay, Lebrun et al. 2005). Similar to the VMH, MC4R 
agonist and MC4R antagonist administration into the DVC increases and decreases BDNF 
protein levels, respectively. Furthermore, orexigenic effects of MC4R antagonist are 
counteracted by the co-administration of BDNF, while anorexigenic effects of MC4R 
agonist are counteracted by the pharmacological inhibition of TrkB, suggesting that 
BDNF/TrkB signaling also acts downstream of melanocortin signaling in the DVC 
(Bariohay, Roux et al. 2009). In the NTS of the DVC, BDNF administration suppresses 
food intake through TrkB signaling in rats, and TrkB antagonist blocks anorexigenic effects 
of leptin, implicating an important role for hindbrain BDNF/TrkB signaling in energy 
balance regulation (Spaeth, Kanoski et al. 2012).  
 
Despite growing evidence of a metabolic role for BDNF/TrkB signaling in the 
hypothalamus (specifically VMH and PVH) and in the hindbrain (specifically NTS), most 
of the published studies so far have focused on BDNF-deficiency, incomplete TrkB 
deletion or the metabolic effects of exogenous BDNF administration. The brain site(s) 
where endogenous BDNF/TrkB signaling is essential in the central regulation of energy 
balance require further investigation.    
 
In addition to its role in homeostatic regulation of energy balance, BDNF is also implicated 
in hedonic control of feeding. The mesolimbic pathway implicated in hedonic regulation of 
energy balance consists of dopamine neurons in the VTA projecting to the NAc and medial 
prefrontal cortex (mPFC) (Van Bockstaele and Pickel 1995, Carr and Sesack 2000). 
Deletion of BDNF in the VTA through AAV-Cre delivery in mice results in increased high-
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fat food but not chow consumption. BDNF regulates the excitability of the dopamine-
secreting neurons in the NAc and the increased HFD consumption is due to deficiency in 
dopamine secretion resulting in impaired dopamine transmission between the VTA and 
the NAc (Cordeira, Frank et al. 2010, Cordeira and Rios 2011).    
 
Adult hypothalamic neurogenesis contributes to the central regulation of energy 
balance  
The hypothalamus has recently been reported as a neurogenic brain region similar to the 
subventricular zone of the lateral ventricle and the subgranular zone of the hippocampal 
dentate gyrus (Kokoeva, Yin et al. 2007). In the hypothalamus, the ependymal layer lining 
the third ventricle is a neurogenic zone where neural progenitor cells (also known as radial 
glia-like tanycytes) proliferate, differentiate into neurons and migrate to the hypothalamic 
parenchyma (Xu, Tamamaki et al. 2005, Migaud, Batailler et al. 2010). This neurogenic 
process occurs under baseline conditions and is enhanced by stimulation with growth and 
trophic factors, including BDNF (Pencea, Bingaman et al. 2001). Interestingly, there is 
growing evidence that adult born hypothalamic neurons play an important role in the 
regulation of body weight, metabolism and energy balance. Some of the newly born 
hypothalamic neurons are leptin-responsive through leptin-induced STAT3 
phosphorylation, and some acquire markers of terminally differentiated neurons such as 
POMC, AGRP, NPY that contribute to energy balance regulation (Kokoeva, Yin et al. 
2007, Pierce and Xu 2010). These studies point to the possibility that the newly born 
hypothalamic neurons play a role in energy balance regulation through neuropeptide 
secretion and/or through direct integration into the hypothalamic circuitry.    
 
Interestingly, HFD and obesity appear to influence adult hypothalamic neurogenesis. HFD 
consumption leads to enhanced neurogenesis in the median eminence of the 
19 
 
hypothalamus. Selective inhibition of neurogenesis in the median eminence leads to 
attenuation of weight gain due to increased energy expenditure and activity in HFD-fed 
mice (Lee, Bedont et al. 2012, Lee, Yoo et al. 2014). The effect is site-specific as HFD 
feeding suppresses neurogenesis in the ARC by reducing the number of neural progenitor 
cells through enhanced apoptosis. Notably, calorie restriction partially restores the 
neurogenesis in the ARC of these DIO mice. ob/ob mice also show impaired neurogenesis 
in the ARC, due to reduced number of neural stem cells (McNay, Briancon et al. 2012).   
 
Despite compelling data implicating BDNF/TrkB signaling in central metabolic control, the 
precise brain region(s) where endogenous TrkB plays a critical role in energy balance 
regulation have not been thoroughly examined. Furthermore, how TrkB signaling in the 
brain is regulated by tyrosine phosphatase activity was not previously known. My thesis 
research was designed to directly test the hypothesis that endogenous hypothalamic and 
hindbrain TrkB signaling is essential to central metabolic control, and that PTP1B is a 
physiological regulator of central BDNF/TrkB signaling. This dissertation examines the role 
of endogenous hypothalamic and hindbrain BDNF/TrkB signaling in the central regulation 
of energy balance and PTP1B’s role in antagonizing this signaling pathway through a 
comprehensive metabolic study using novel genetic mouse models in vivo and a thorough 
signaling study in an immortalized human neuronal cell line in vitro. As detailed in Chapter 
2, we established a novel role for PTP1B as a bona fide negative regulator of central 
BDNF/TrkB signaling pathway using SH-SY5Y-TrkB human neuroblastoma cell line and 
Ptpn1-/- mouse model of global PTP1B-deficiency. As discussed in Chapter 3, we 
assessed whether Ptpn1-/- mice display enhanced adult hypothalamic neurogenesis, 
possibly through sensitized BDNF/TrkB signaling in the hypothalamus. Chapter 4 details 
our comprehensive metabolic phenotyping of hypothalamus-specific (Nkx2.1-Ntrk2-/-) or 
hindbrain-specific (Phox2b-Ntrk2-/-) TrkB-deficient mice to determine whether intact 
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endogenous hypothalamic and/or hindbrain BDNF/TrkB signaling is crucial to the 
maintenance of energy homeostasis. Finally, in Chapter 5 we discuss our findings within 
the context of central control of metabolism and propose future directions for additional 
studies.      
 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Homeostatic and hedonic feeding circuits in the brain, simplified (top) 
Hypothalamic feeding circuits, emphasizing melanocortin signaling pathway (bottom) 
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Abstract 
Neuronal protein tyrosine phosphatase 1B (PTP1B)-deficiency in mice results in 
enhanced leptin signaling and protection from diet-induced obesity; however, whether 
additional signaling pathways in the brain contribute to the metabolic effects of PTP1B-
deficiency remains unclear. Here we show that the tropomyosin receptor kinase B (TrkB) 
receptor is a direct PTP1B substrate and implicate PTP1B in the regulation of the central 
brain-derived neurotrophic factor (BDNF) signaling. PTP1B interacts with the activated 
TrkB receptor in mouse brain and human SH-SY5Y neuroblastoma cells. PTP1B 
overexpression reduces TrkB phosphorylation and activation of downstream signaling 
pathways whereas PTP1B inhibition augments TrkB signaling. Notably, brains of Ptpn1-
/- mice exhibit enhanced TrkB phosphorylation, and Ptpn1-/- mice are hypersensitive to 
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central BDNF-induced increase in core temperature. Taken together, our findings 
demonstrate that PTP1B is a novel physiological regulator of TrkB and that enhanced 
BDNF/TrkB signaling may contribute to the beneficial metabolic effects of PTP1B-
deficiency.  
 
Introduction 
Energy homeostasis is a complex process that involves numerous tightly-regulated 
signaling pathways, and its dysregulation can lead to obesity (reviewed in (Flier 2004)). 
PTP1B is implicated in the regulation of energy balance; single nucleotide 
polymorphisms within the human PTPN1 gene are associated with obesity and 
metabolic disorders (reviewed in (Tsou and Bence 2012)), and deletion of PTP1B in 
mice (Ptpn1-/-) results in reduced adiposity and resistance to diet-induced obesity 
(Elchebly, Payette et al. 1999, Klaman, Boss et al. 2000).   
 
PTP1B antagonizes the action of the adipocyte-secreted hormone leptin by directly 
dephosphorylating the leptin receptor-associated Janus kinase 2 (Myers, Andersen et al. 
2001, Cheng, Uetani et al. 2002, Kaszubska, Falls et al. 2002, Zabolotny, Bence-
Hanulec et al. 2002). Leptin acts within the brain to regulate energy homeostasis by 
suppressing food intake and elevating energy expenditure, and the metabolic effects of 
central PTP1B-deficiency have been attributed to improved leptin sensitivity (Bence, 
Delibegovic et al. 2006, Banno, Zimmer et al. 2010, De Jonghe, Hayes et al. 2012, Tsou, 
Zimmer et al. 2012, Tsou, Rak et al. 2014). Mice with compound deletion of leptin and 
PTP1B (ob/ob:Ptpn1-/-) weigh less than obese ob/ob mice, suggesting possible leptin-
independent metabolic effects of PTP1B-deficiency (Cheng, Uetani et al. 2002). Indeed 
PTP1B has other known protein substrates that are implicated in metabolic control 
including the insulin receptor (Kenner, Anyanwu et al. 1996), yet the relative contribution 
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of specific signaling pathways to the metabolic effects of PTP1B-deficiency still remain to 
be determined (reviewed in (Tiganis and Bennett 2007)). 
 
Biochemical and structural studies have revealed a substrate recognition motif that, in 
addition to being present in known targets of PTP1B (Kenner, Anyanwu et al. 1996, Flint, 
Tiganis et al. 1997, Myers, Andersen et al. 2001), is present in the receptor tyrosine 
kinase domain of the tropomyosin receptor kinase (Trk) family of proteins (Espanel, 
Huguenin-Reggiani et al. 2002). Notably, the TrkB receptor and its ligand, brain-derived 
neurotrophic factor (BDNF), are key players in the regulation of energy homeostasis 
(reviewed in (Cordeira and Rios 2011, Rios 2013, Vanevski and Xu 2013)). The 
hypothalamus and the hindbrain are two major regions within the brain that are 
implicated in BDNF regulation of metabolism, although both BDNF and the TrkB 
receptor are broadly distributed throughout the central nervous system (Yan, Radeke et 
al. 1997, Ohira and Hayashi 2009). Intraparenchymal administration of BDNF into the 
ventromedial nucleus (VMH) and paraventricular nucleus (PVH) of the hypothalamus 
reduces food intake and increases energy expenditure (Wang, Bomberg et al. 2007, 
Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2010, 
Wang, Godar et al. 2010, Godar, Dai et al. 2011). Similarly, delivery of BDNF directly 
into the dorsal vagal complex (Bariohay, Lebrun et al. 2005, Bariohay, Roux et al. 2009) 
or nucleus tractus solitarius (NTS, or nucleus of the solitary tract) (Spaeth, Kanoski et al. 
2012) of the hindbrain reduces food intake and increases energy expenditure.  
 
Here we show that PTP1B is a novel physiological regulator of BDNF/TrkB signaling in 
neurons. Mice lacking PTP1B are hypersensitive to central BDNF-induced increased 
core temperature, suggesting that alterations in this signaling pathway may be mediating 
some of the beneficial metabolic effects induced by disruption of PTP1B. These studies 
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have important implications for the future use of PTP1B inhibitors in the treatment of 
obesity and metabolic disease. 
 
Materials and Methods 
Animal care. Ptpn1-/- mice were generated and genotyped as previously described 
(Tsou, Zimmer et al. 2012). Individually housed adult male Ptpn1-/- mice and their wild 
type littermates (on a 129Sv/J x C57BL/6 background) were maintained in a 
temperature-controlled barrier facility on a 12:12 hour light:dark cycle with ad libitum 
access to water and standard chow (Purina Rodent Chow 5001) or custom high-fat diet 
(Teklad TD93075; calories provided by protein (21.2%), fat (54.8%), and carbohydrate 
(24%)) for 12 weeks upon weaning (3 weeks of age) where indicated. All procedures 
were approved by University of Pennsylvania Institutional Animal Care and Use 
Committee. 
 
Constructs. pGEX4T.1-hPTP1B and pMT2-hPTP1B constructs (and all parental 
vectors) were supplied by Dr. Benjamin Neel (Ontario Cancer Institute). pLNCX2-hTrkB 
was supplied by Dr.Garrett Brodeur (Children’s Hospital of Philadelphia). The 
pGEX4T.1-hPTP1B-D181A:Y46F substrate trapping mutant of PTP1B, the pMT2-hPTP1B-
C215S catalytically inactive mutant of PTP1B, and the TrkB kinase mutants pLNCX2-
hTrkB-Y702/706/707F and Y706/707F were generated using a standard site-directed 
mutagenesis kit (QuikChange II, Agilent Technologies).  
 
Cell culture. SH-SY5Y-TrkB cells stably expressing human TrkB were a generous gift of 
Dr. Garrett Brodeur (Children’s Hospital of Philadelphia) and were maintained at 37°C in 
95%/5% O2/CO2 chamber in RPMI-1640 medium (GIBCO) supplemented with 10% fetal 
bovine serum (FBS) (Hyclone), 100 I.U. penicillin and 100 µg/ml streptomycin (Invitrogen 
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Life Technologies). Cells were cultured in the presence of 200 µg/ml geneticin (G418) 
(Cellgro) to maintain TrkB expression. Where indicated, cells were stimulated with 
human recombinant BDNF (R&D Systems) or vehicle (PBS for BDNF and DMSO for 
PTP1B inhibitor).  
 
Transient transfection. For PTP1B overexpression studies, SH-SY5Y-TrkB cells were 
transiently transfected with eukaryotic expression constructs of PTP1B (WT PTP1B, 
C215S PTP1B or parental pMT2 vector) using the polyethylenimine (PEI) method. Briefly, 
DNA was diluted in RPMI medium and mixed with PEI (Polysciences, Inc.) at 1:4 
DNA:PEI for 15 minutes at room temperature. This mixture was directly added to the 
cells, which were then incubated at 37oC in 95%/5% O2/CO2 chamber overnight. 
Experiments were performed approximately 24 hours after transfection.  
 
Retroviral transduction and stable cell lines. SH-SY5Y parental cells were infected 
with retroviruses expressing tyrosine-kinase dead constructs of TrkB (Y702/706/707F or 
Y706/707F in pLNCX2 retroviral vector) using the retroviral transduction method. Briefly, 
Plat-E packaging cells were transiently transfected using the PEI method. Retroviral 
supernatants were filter-sterilized, mixed with polybrene (5 µg/ml) (Sigma), and directly 
added to the SH-SY5Y-TrkB cells, which were incubated at 37oC in a 95%/5% O2/CO2 
chamber for 48 hours. Approximately 24 hours after transfection, the mixture was 
removed and replaced with fresh medium. Cells were allowed to recover for an 
additional 24 hours and pools of infected cells were selected with 600 µg/ml G418 
(based on a G418 kill curve) for 2 weeks prior to experiments.  
 
Recombinant protein production and purification. BL21(DE3)pLysS competent cells 
(Stratagene) were transformed with bacterial expression constructs of PTP1B 
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(pGEX4T.1-PTP1B-WT, pGEX4T.1-PTP1B-D181A:Y46F or parental pGEX4T.1 vector) 
according to the manufacturer’s instructions. Recombinant protein production and 
purification was adapted from a previous protocol (Blanchetot, Chagnon et al. 2005). 
Briefly, 0.1mM isopropyl-1-thio-β-D-galactopyranoside (IPTG) was added to the bacterial 
cultures at an optical density of 0.6 to induce expression of recombinant proteins for 4 
hours at 37oC. Bacterial pellets were lysed in ice-cold lysis buffer (10 mM Tris pH 8.0, 
150 mM sodium chloride, 1 % Triton-X100, 10 mM dithiothreitol and 1X bacterial 
protease inhibitor cocktail (Roche)) and sonicated on ice. Lysates were centrifuged, and 
the supernatants were incubated with glutathione sepharose beads (GE Healthcare) for 
1 hour at 4oC. Collected beads were washed three times in lysis buffer at 4oC. 
Recombinant proteins were eluted from the beads in six fractions with glutathione elution 
buffer (10 mM reduced glutathione in 50 mM Tris pH 8.0 with 10 mM dithiothreitol and 
1X bacterial protease inhibitors) at 4oC. Supernatants containing the purified 
recombinant proteins were dialyzed into 1X TBS with 10 mM dithiothreitol and 10 % 
glycerol using Slide-A-Lyzer® dialysis cassettes (10,000 MWCO; Thermo Scientific). 
Enzymatic activity of purified PTP1B proteins was tested using a colorimetric 
phosphatase assay (BML-AK822, Enzo Life Sciences).  
 
Substrate trapping. For glutathione-S-transferase (GST) pull-down experiments, brain 
or SH-SY5Y-TrkB cell lysates were prepared in NP-40 buffer (150 mM sodium chloride, 
20 mM Tris pH 7.4, 5 mM EDTA, 10 mM sodium pyrophosphate, 1 % NP-40, 50 mM 
sodium fluoride, 10 mM β-glycerophosphate) with protease inhibitor cocktail (1:100 
dilution; Roche) with or without sodium orthovanadate (2 mM) (Sigma). Recombinant 
proteins were conjugated to glutathione sepharose beads (GE Healthcare) for 1 hour at 
4oC. Lysed samples were incubated with bead-bound recombinant proteins for 4 hours 
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at 4oC. Protein complexes were washed four times in lysis buffer at 4oC and prepared for 
immunoblotting (as described below).  
 
Immunoblotting. For BDNF signaling studies in SH-SY5Y-TrkB cell line, lysates were 
prepared in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 0.1 % SDS, 
1 % Triton X-100, 1 % sodium deoxycholate, 5 mM EDTA,1 mM sodium fluoride) with 
protease inhibitor cocktail (1:100 dilution), and sodium orthovanadate (2 mM). Protein 
concentrations were determined using a BCA Protein Assay (Thermo Scientific), and 
proteins were resolved by SDS-PAGE and transferred to PVDF membrane. 
Immunoblots were performed using the following antibodies: p-TrkB (Y706) (sc-135645, 
Santa Cruz Biotechnology, Inc.), p-AKT (Ser473) (193H12, Cell Signaling Technology), 
Phospho-p44/42 MAPK (Thr202/Tyr204) (9101, Cell Signaling Technology), Trk (C-14) 
(sc-11, Santa Cruz Biotechnology, Inc.), AKT (9272, Cell Signaling Technology), p44/42 
MAPK (137F5, Cell Signaling Technology), GST (2622, Cell Signaling Technology), 
homemade mouse PTP1B antibody (Klaman, Boss et al. 2000), PTP1B (H-135), (sc-
14021, Santa Cruz Biotechnology, Inc), PTP1B (FG6, Oncogene Sciences), and SH-
PTP2 (C-18) (sc-280, Santa Cruz Biotechnology, Inc). Proteins were visualized using 
enhanced chemiluminescence by HRP-linked mouse or rabbit secondary antibodies (GE 
Healthcare) and quantified by ImageJ software. 
 
Neurite outgrowth assay. SH-SY5Y-TrkB cells were plated at 1x106 cells/per plate on 
poly-D-lysine (100 µg/ml) coated 60 mm plates (Millipore). Cells were pretreated with 
PTP1B inhibitor (compound II, 500 nM for 5 minutes; (Xie, Lee et al. 2003)) or vehicle 
(DMSO) prior to stimulation with BDNF (25 ng/ml) (R&D Systems) or vehicle (PBS). 
Cells were visualized prior to and 2, 4, 6 and 24 hours following BDNF stimulation using 
a Nikon Eclipse TS100 microscope at 20X magnification and Nikon Coolpix S10 camera 
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at 10X magnification. Primary neurite length was quantified using Image J software 
(NeuronJ plugin). Five neurites from a representative field were measured and averaged 
for each time point, and the experiment was repeated three separate times.  
 
Central BDNF-induced metabolic effects. Individually housed, ad libitum fed, 4-5 
month old Ptpn1-/- male mice (n = 5) and their wild type littermates (n = 10) were used in 
this study. Mice were injected intramuscularly with a mixture of ketamine (9 mg/kg), 
xylazine (0.27 mg/kg), and acepromazine (0.064 mg/kg) into the right hindlimb. 
Following anesthesia, the mice had the head shaved, cleaned with antiseptic and an 
incision was made starting from rostral to bregma and extending just beyond occipital 
notch. Mouthpiece and earbars of the digital stereotaxic apparatus (KOPF) were 
adjusted so that bregma and lambda were on the same dorsal-ventral coordinate. Using 
a high-speed dental drill (Fine Science Tools), a small hole was drilled 0.3 mm posterior 
to bregma and 0.9 mm lateral to the midsaggital suture. Chronic in-dwelling cannulae 
(C315GS-4-SPC, Plastics One) were lowered 1.5 mm ventral from dura. Cannulae were 
attached to the skull with glue adhesive and closed with an obturator. During the same 
surgery, miniature telemetric transponders (G2 E-mitters, Mini Mitter) were securely 
anchored to the abdominal muscle wall as described previously (Spaeth, Kanoski et al. 
2012). Following surgery, mice were given approximately a week to fully recover. 
Correct cannula placement was tested through a single i.c.v. injection of NPY (5 µg/ul) 
(Sigma). Only mice that showed >0.5 g food intake in the 1 hour post-injection period 
were included in the study. Carrier-free human recombinant BDNF (0.05 µg/ul and 0.2 
µg/ul) (R&D Systems) was prepared fresh in artificial cerebrospinal fluid (aCSF) 
(Harvard Apparatus). All injections were given at the onset of the dark cycle in a within-
subjects design. Using a syringe pump (Harvard Apparatus PHD 4400 Hpsi 
Programmable Syringe Pump), mice received a single 1 µl i.c.v. infusion of BDNF or 
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aCSF at a rate of 1  µl/minute. The injector tip was held in place for 30 seconds post-
infusion. Chow intake was determined by weighing the food pellets (Purina Rodent 
Chow 5001) to the nearest 0.1 g before and 1, 3 and 6 hours post drug delivery. Body 
weight was measured to the nearest 0.1 g before and 24 hours post drug delivery. Core 
body temperature and locomotor activity were automatically recorded (VitalView 
Software) via minimitter every 5 minutes for 24 hours following drug delivery. For 
substrate trapping experiments, mice were injected with 0.5 µg BDNF and euthanized 45 
minutes later.  
 
Statistical analysis. Results are expressed as mean ± SEM. Graphs show quantified 
results from at least three separate experiments and the blots are representative. 
Statistical analyses were performed using Prism (GraphPad) software. Comparisons 
between groups were made by unpaired two-tailed Student’s t test, one-way analysis of 
variance or two-way analysis of variance with Bonferroni’s multiple comparison test used 
for post-hoc comparisons, as appropriate. p-values of <0.05 were considered statistically 
significant. 
 
Results 
PTP1B overexpression suppresses BDNF/TrkB signaling.  
Given that the Trk family of receptors contains an ideal PTP1B target sequence and that 
the TrkB receptor ligand BDNF is an important central regulator of metabolism, we 
tested whether increasing levels of PTP1B antagonizes BDNF/TrkB signaling. BDNF 
stimulation results in TrkB receptor dimerization and autophosphorylation of tyrosine 
residues, including Y702 and Y706/Y707 in the tyrosine kinase domain. This in turn triggers 
activation of different signaling cascades including PI3-Kinase/AKT, Ras stimulation of 
ERK and PLCγ-1 activation (reviewed in (Reichardt 2006)). In neuronal SH-SY5Y cells 
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stably expressing wild type TrkB receptor (hereafter referred to as SH-SY5Y-TrkB), 
transient overexpression of wild type PTP1B significantly suppresses BDNF-induced 
phosphorylation of the TrkB receptor on Y706 and activation of its downstream targets, 
AKT and ERK (Figure 1A,B). Expression of a catalytically inactive mutant (C215S) of 
PTP1B has no effect on TrkB, AKT or ERK phosphorylation levels (Figure 1A,B), 
suggesting that the phosphatase activity of PTP1B is required for PTP1B’s effects on 
TrkB signaling. Expression of wild type PTP1B suppresses peak BDNF-induced TrkB 
phosphorylation at 30 minutes (Figure 1C), suggesting that PTP1B plays a negative 
regulatory role in BDNF-induced TrkB phosphorylation. Expression of wild type PTP1B 
does not significantly alter the dose-response to BDNF at the 5 minute BDNF time point 
(Figure 1D). 
 
PTP1B inhibition or genetic PTP1B-deficiency enhances BDNF/TrkB signaling.  
Inhibition of PTP1B activity sensitizes the leptin and insulin signaling pathways in vitro 
and in vivo (Zinker, Rondinone et al. 2002, Morrison, White et al. 2007, Ma, Tao et al. 
2011). To investigate whether acute inhibition of PTP1B activity similarly enhances 
BDNF/TrkB signaling, SH-SY5Y-TrkB cells were pretreated with a cell-permeable 
PTP1B-specific inhibitor (compound II, 100 nM for 5 minutes (Xie, Lee et al. 2003)) or 
vehicle prior to either vehicle or BDNF stimulation. PTP1B inhibition significantly 
increases BDNF-induced phosphorylation of the TrkB receptor on Y706 and enhances 
activation of its downstream targets, AKT and ERK (Figure 2A,B), showing that 
endogenous PTP1B acts as a physiological “brake” on TrkB signaling. PTP1B inhibitor 
pretreatment affects both the time course and the dose response of BDNF-induced TrkB 
phosphorylation (Figure 2C,D). Given our in vitro findings, we examined endogenous 
levels of phosphorylated TrkB in the hypothalamus of high-fat diet-fed PTP1B-deficient 
mice compared to wild type littermate controls. Male Ptpn1-/- mice fed a high-fat diet for 
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12 weeks show increased levels of hypothalamic TrkB phosphorylation on Y706 
compared to their wild type littermates (Figure 3A). No differences in p-TrkB or total TrkB 
protein are noted in hypothalamus of mice fed a chow diet (data not shown). TrkB 
receptors are highly expressed in the hippocampus (Klein, Martin-Zanca et al. 1990, 
Webster, Herman et al. 2006); notably, levels of p-TrkB are also elevated in this brain 
region of Ptpn1-/- mice compared to wild type littermates (Figure 3B).  
 
PTP1B interacts with the TrkB receptor.  
Although previous biochemical and in vitro peptide phosphorylation studies show a likely 
PTP1B substrate recognition motif in the receptor tyrosine kinase domain of TrkB 
(Espanel, Huguenin-Reggiani et al. 2002), this interaction has not been confirmed in a 
physiologically relevant context. To test whether the TrkB receptor is indeed a bona fide 
PTP1B substrate, we utilized substrate trapping mutants of PTP1B that have reduced 
catalytic activity despite retained substrate binding ability (Flint, Tiganis et al. 1997). A 
robust substrate trapping mutant of PTP1B was generated by introducing two point 
mutations (D181A:Y46F) in the WPD and YRD loops surrounding the catalytic domain of 
the enzyme (Boubekeur, Boute et al. 2011). As shown in Figure 4A, GST-PTP1B-
D181A:Y46F stably binds to the tyrosine phosphorylated TrkB receptor when incubated 
with BDNF-stimulated SH-SY5Y-TrkB cell lysates in vitro (Figure 4A, left panel lane 3). 
PTP1B phosphatase activity is required for this association because the GST-PTP1B-
D181A:Y46F interaction with TrkB is abolished in the presence of a competitive 
phosphatase inhibitor, sodium orthovanadate (Figure 4A, left panel lane 4). No binding 
of TrkB is detected to GST alone or GST-PTP1B-WT, showing that there is no non-
specific binding of TrkB to GST, and that the phosphatase-substrate interaction is likely 
rapid and transient (Figure 4A, left panel lanes 1 and 2, respectively). To define the 
critical tyrosines mediating the PTP1B-TrkB interaction, two kinase-dead TrkB constructs 
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with mutations corresponding to the active site tyrosine residues in the receptor tyrosine 
kinase domain (Y702/706/707F and Y706/707F) were generated and stably expressed in SH-
SY5Y parental cells that do not express endogenous TrkB receptors. The PTP1B-TrkB 
interaction is completely disrupted when GST-PTP1B-D181A:Y46F is incubated with TrkB 
mutant stable cell lysates (Figure 4A, left panel lanes 5 (Y702/706/707F) and 6 (Y706/707F)), 
demonstrating that these tyrosine residues are necessary for this interaction. Binding of 
TrkB to GST-PTP1B-D181A:Y46F (or to GST alone or GST-PTP1B-WT) is not detected in 
the absence of BDNF stimulation, suggesting that this association is ligand-dependent 
and requires receptor phosphorylation (Figure 4A, right panel lanes 1-3). Overall, these 
data show that BDNF-induced tyrosine phosphorylation of the TrkB receptor activation 
site is necessary for PTP1B binding to TrkB. In addition to these in vitro findings, GST-
PTP1B- D181A:Y46F stably associates with the activated TrkB receptor in brain lysates of 
mice injected i.c.v. with recombinant BDNF as shown by GST pull-down assay (Figure 
4B, lane 3). No association is detected with GST-PTP1B-WT using this protocol (Figure 
4B, lane 2), again likely due to the rapid and transient nature of the phosphatase-
substrate interaction. As a control, no binding is detected when using GST alone (Figure 
4B, lane 1).     
  
Metabolic effects of acute central BDNF delivery in Ptpn1-/- mice and wild type 
mice.  
To determine the metabolic response of Ptpn1-/- mice to exogenous BDNF, male Ptpn1-
/- mice and their wild type littermates were given a single dose of BDNF or aCSF 
(vehicle) i.c.v. into the lateral ventricle just prior to the onset of the dark cycle. BDNF 
delivery into the brain has previously been shown to reduce food intake and suppress 
body weight in rodents (reviewed in (Rios 2013)). Both Ptpn1-/- mice and their wild type 
littermates display significantly reduced cumulative food intake at 3 and 6 hours after 
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administration of BDNF compared to aCSF (Figure 5A). Similarly, body weight is 
suppressed to a similar extent in both genotypes 24 hours after BDNF administration 
(calculated as % body weight suppression compared to aCSF vehicle; Figure 5B). 
 
In addition to its effects on food intake, BDNF administration into the VMH and PVH of 
the hypothalamus as well as the NTS of the hindbrain increases energy expenditure 
through changes in spontaneous physical activity, resting metabolic rate, core 
temperature and thermogenic gene expression (Wang, Bomberg et al. 2007, Wang, 
Bomberg et al. 2010, Spaeth, Kanoski et al. 2012). To test the hypothesis that PTP1B-
deficient mice may display differential energy expenditure responses to exogenous 
BDNF, core body temperature and spontaneous physical activity were recorded in 
Ptpn1-/- and wild type littermates in response to aCSF or a lower dose of BDNF that 
doesn’t reduce food intake in either group (data not shown). Ptpn1-/- mice show 
significantly elevated core temperature in response to BDNF in both the dark and light 
cycles compared to aCSF delivery, whereas this dose of BDNF does not induce 
elevated core temperature in wild type controls (Figure 5C). As expected, all groups 
display higher core temperatures during the dark cycle when mice are more active.  A 
single dose of BDNF does not alter locomotor activity compared to vehicle in either 
genotype (data not shown).  Results of these in vivo studies support a novel role for 
PTP1B in regulating BDNF/TrkB-induced signaling within the brain, and suggest that 
enhanced central BDNF signaling may contribute to the increased energy expenditure 
noted in mouse models of PTP1B-deficiency.  
 
Acute pretreatment with a PTP1B-specific inhibitor increases BDNF-induced 
primary neurite outgrowth.  
34 
 
BDNF is a neurotrophic factor and is crucial for many aspects of neuronal development 
including neuronal survival, differentiation, and connectivity through axonal arborization 
and dendritic branching (reviewed in (Reichardt 2006, Jeanneteau, Deinhardt et al. 
2010)). To determine whether PTP1B affects BDNF-induced neurite outgrowth, SH-
SY5Y-TrkB cells were pretreated with vehicle or a cell permeable PTP1B-specific 
inhibitor (compound II, 500 nM for 5 minutes (Xie, Lee et al. 2003)) prior to BDNF or 
vehicle stimulation. Primary neurite outgrowth was assessed prior to and at 2, 4, 6 and 
24 hours following BDNF stimulation. PTP1B inhibitor pretreatment results in a 
significant increase in primary neurite length as early as 2 hours post-BDNF and remains 
significantly higher throughout the experiment compared to cells without PTP1B inhibitor 
treatment (Figure 6A and B). These results demonstrate that PTP1B plays a role in 
regulating BDNF-induced neurite outgrowth in vitro and raises the intriguing possibility 
that central PTP1B-deficiency could influence BDNF-mediated neural plasticity in the 
brain.  
 
Discussion 
PTP1B is a known regulator of central metabolism, at least partially via negative 
regulation of leptin signaling. However, PTP1B is a ubiquitously expressed phosphatase 
with many substrate targets that are implicated in metabolic control, and whether PTP1B 
regulates other pathways that are relevant to energy balance regulation is yet to be 
determined. Peptide studies have revealed a substrate recognition motif that, in addition 
to being present in known substrates of PTP1B, is present in the Trk family of receptors 
suggesting a possible PTP1B-Trk receptor interaction. Using both a neuronal cell line 
and a genetic mouse model of PTP1B-deficiency, we find that PTP1B is indeed a novel 
physiological regulator of central BDNF/TrkB signaling and BDNF-induced increase in 
core temperature.  
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In SH-SY5Y-TrkB cells, PTP1B overexpression impairs TrkB signaling. Furthermore, our 
data show that the interaction of PTP1B and TrkB requires PTP1B phosphatase activity 
and BDNF-induced TrkB tyrosine phosphorylation at the active site tyrosines Y706/707. 
Notably, elevated PTP1B expression occurs in the obese state in vivo and PTP1B 
expression is induced by a variety of factors including diet, inflammation, and ER stress 
(reviewed in (Tsou and Bence 2012)).  
 
PTP1B is thought to play a complex role in interacting with and modulating the activity of 
its protein substrates (reviewed in (Stuible and Tremblay 2010)). TrkB is a 
transmembrane receptor tyrosine kinase whereas PTP1B is an intracellular phosphatase 
that is localized to cytoplasmic face of the endoplasmic reticulum (Frangioni, Beahm et 
al. 1992). It is conceivable that the PTP1B-TrkB interaction and TrkB receptor 
dephosphorylation occur after ligand-induced receptor internalization, similar to 
epidermal growth factor (EGFR) and platelet-derived growth factor (PDGFR) receptors 
(Haj, Verveer et al. 2002). Alternatively, a protein complex may recruit PTP1B for TrkB 
receptor dephosphorylation, as is the case for insulin receptor (IR) signaling (Wu, 
Buszard et al. 2011). Yet another possible mechanism is cleavage and subcellular 
relocalization of a truncated, active form of PTP1B into the cytosol (Frangioni, Oda et al. 
1993). The precise biochemical mechanism by which PTP1B attenuates TrkB signaling 
needs further investigation. Interestingly, TrkB signaling is known to be modulated by 
other protein tyrosine phosphatases (Rusanescu, Yang et al. 2005, Yang, Massa et al. 
2006, Ambjorn, Dubreuil et al. 2013, Gatto, Dudanova et al. 2013) but how or whether 
PTP1B interacts with these proteins to regulate TrkB signaling remains unknown.  
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In SH-SY5Y-TrkB cells, PTP1B inhibition enhances TrkB signaling. It will be crucial to 
determine whether the observed in vitro effects of acute PTP1B inhibition on TrkB 
signaling are recapitulated in vivo through either PTP1B inhibitor administration into 
brain regions where TrkB is highly expressed or by chronic administration of BDNF in 
mouse models of central PTP1B-deficiency.  
 
The improved metabolic phenotype of whole body PTP1B-deficient mice is recapitulated 
in brain-specific PTP1B-deficient mice (Bence, Delibegovic et al. 2006), implicating the 
central nervous system as the primary site of PTP1B’s metabolic effects. Within the 
central nervous system, the hypothalamus (Tsou, Rak et al. 2014) and the hindbrain (De 
Jonghe, Hayes et al. 2012) have been identified as important sites of metabolic 
regulation by PTP1B. Notably, these same brain regions have been previously identified 
as major sites of BDNF and TrkB expression and implicated in mediating BDNF’s 
metabolic effects (reviewed in (Rios 2013)). Consistent with a role for PTP1B in 
regulating hypothalamic TrkB signaling, we find that high-fat diet-fed Ptpn1-/- mice 
display increased TrkB active site phosphorylation. Given that high-fat diet feeding has 
previously been shown to impair TrkB phosphorylation in the brain (Sharma, Zhuang et 
al. 2012, Woo, Shin et al. 2013), enhanced central TrkB activation in the absence of 
PTP1B may play a role in mediating some of the beneficial metabolic effects in Ptpn1-/- 
mice.  A previous study from our lab (Tsou, Rak et al. 2014) has emphasized the 
importance of intact hypothalamic leptin signaling for PTP1B’s metabolic effects; 
however, incomplete recapitulation of the metabolic phenotype of brain-specific PTP1B-
deficiency with hypothalamus-specific PTP1B-deficiency suggests the importance of 
extra-hypothalamic sites such as the hindbrain for PTP1B’s metabolic effects. In fact, 
sensitivity to hindbrain/NTS BDNF may underlie the enhanced thermogenic response to 
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4th i.c.v. BDNF (Spaeth, Kanoski et al. 2012). It remains to be determined whether 
PTP1B regulates BDNF/TrkB signaling in the hindbrain.   
 
BDNF is a key neurotrophic factor implicated in neural connectivity specifically through 
enhancing axonal arborization and neurite outgrowth (Jeanneteau, Deinhardt et al. 
2010). PTP1B has previously been shown to enhance neurite extension in PC12 cells 
(Pathre, Arregui et al. 2001) and to influence plasticity in hippocampal neurons (Fuentes, 
Zimmer et al. 2012). Present data show that pretreatment with PTP1B inhibitor increases 
BDNF-induced neurite outgrowth in SH-SY5Y-TrkB cells. Although the molecular 
mechanism behind this effect is yet unknown, one possibility is that 
hyperphosphorylation of the TrkB receptor due to PTP1B inhibition results in receptor 
internalization followed by trafficking through signaling endosomes and consequent 
delivery to specific parts of the neurons to induce neurite outgrowth (Lazo, Gonzalez et 
al. 2013). In the context of metabolic control, this interesting finding leads us to 
speculate that disruption of PTP1B may lead to altered developmental wiring and/or 
plasticity-induced re-wiring of brain regions implicated in metabolic control due to 
augmented BDNF/TrkB signaling. Given that leptin also has trophic effects in the 
hypothalamus (Bouret, Gorski et al. 2008), sensitization to BDNF and leptin in the 
absence of PTP1B may act synergistically to affect these processes, which may 
contribute to the overall improved metabolic phenotype of Ptpn1-/- mice.  
 
Exogenous BDNF administration into the brain reduces energy intake and increases 
energy expenditure, leading to overall body weight loss in rodents (Pelleymounter, 
Cullen et al. 1995, Bariohay, Lebrun et al. 2005, Wang, Bomberg et al. 2007, Wang, 
Bomberg et al. 2007, Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2010, Wang, 
Godar et al. 2010, Spaeth, Kanoski et al. 2012). Our data indicate that acute BDNF 
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administration into the lateral ventricle reduces food intake and body weight in Ptpn1-/- 
mice and wild type littermates to a similar extent. Although there are no differential 
energy intake effects between genotypes with our dose and injection paradigm, Ptpn1-/- 
mice are more sensitive to BDNF-induced increase in core temperature compared to 
wild type littermates. Previous studies on the energy intake and expenditure effects of 
BDNF were conducted using rats and employing acute or chronic BDNF administration 
to the ventricles or targeted to specific nuclei of the hypothalamus or the hindbrain 
(Bariohay, Lebrun et al. 2005, Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2007, 
Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2010, Wang, Godar et al. 2010, 
Spaeth, Kanoski et al. 2012). To our knowledge, this is the first study examining the 
metabolic effects of acute BDNF administration into the lateral ventricle of mice. 
Intraparenchymal BDNF injections into different brain regions of interest will further 
elucidate the key brain regions that are responsible for metabolic effects observed in 
Ptpn1-/- mice. Notably, BDNF expression is induced by leptin through melanocortin 
signaling in both the hypothalamus (Xu, Goulding et al. 2003) and the hindbrain 
(Bariohay, Roux et al. 2009); thus, the observed effects might not completely be leptin-
independent and will require further investigation.  
 
Taken together, our results suggest a previously unidentified role of PTP1B in central 
BDNF/TrkB signaling. These intriguing results bring us one step closer to understanding 
the role of BDNF/TrkB pathway in energy balance regulation, as well as PTP1B’s 
mechanism of action in exerting its metabolic effects. Importantly, these results open up 
new avenues for understanding PTP1B regulation of Trk signaling in the context of 
neurodevelopment and neuronal plasticity in addition to metabolism.  
 
 
 

Figure 2.1 continued
(A) SH-SY5Y-TrkB cells were transiently transfected with
eukaryotic expression vectors of PTP1B (WT, C215S PTP1B or
parental pMT2 vector) using the PEI method. Cells were
stimulated with BDNF (25 ng/ml) or vehicle (PBS) for 5 minutes.
Representative anti-phosphoTrkB, anti-phosphoAKT, anti-
phosphoERK, anti-TrkB, anti-AKT, anti-ERK, anti-human PTP1B,
and anti-SHP2 immunoblots of total lysates are shown and
quantified in (B). Data are represented as mean ± SEM (n = 3, *p <
0.05 compared to empty vector group, Student’s t test). (C-D)
Lysates were immunoblotted with anti-phosphoTrkB and anti-
SHP2. BDNF dose for each time point in panel C is 25 ng/ml. Time
point for each dose in panel D is 5 minutes. Graphs show
quantified results from at least three separate experiments and
representative blots are shown. Dashed lines show where the
image from the same blot was cropped. Data are represented as
mean ± SEM (n = 3, *p < 0.05 compared to empty vector group,
two-way ANOVA with post hoc Bonferroni test).
40

Figure 2.2 continued
(A) SH-SY5Y-TrkB cells were pretreated with cell-permeable
PTP1B-specific inhibitor (compound II (100 nM)) or vehicle
(DMSO) for 5 minutes prior to stimulation with BDNF (25 ng/ml) or
vehicle (PBS) for 5 minutes. Representative anti-phosphoTrkB,
anti-phosphoAKT, anti-phosphoERK, anti-TrkB, anti-AKT, anti-
ERK and anti-SHP2 immunoblots of total lysates are shown and
quantified in (B). Data are represented as mean ± SEM (n = 3, *p <
0.05 compared to control group, Student’s t test). (C-D) Lysates
were immunoblotted with anti-phosphoTrkB and anti-SHP2. BDNF
dose for each time point in panel C is 25 ng/ml, time point for
each dose in panel D is 5 minutes. Graphs show quantified
results from at least three separate experiments and
representative blots are shown. Dashed lines show where the
image from the same blot was cropped. Data are represented as
mean ± SEM, (n = 3, *p < 0.05 compared to control group, two way
ANOVA with post hoc Bonferroni test).
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Figure 2.3 continued
(A) Hypothalamic TrkB phosphorylation in 15 week old, male
Ptpn1-/- mice and wild type littermates after 12 weeks of high-fat
diet feeding. Representative immunoblots of lysates using anti-
phosphoTrkB, anti-TrkB, anti-mouse PTP1B and anti-SHP2
antibodies are shown. Data are represented as mean ± SEM (n = 4
for wild-type and n = 3 for Ptpn1-/-, *p < 0.05 compared to wild type
group, Student’s t test). (B) Hippocampal TrkB phosphorylation in
15 week old, male Ptpn1-/- mice and wild type littermates after 12
weeks of high-fat diet feeding. Dashed lines show where the image
from the same blot was cropped. Representative immunoblots of
lysates using anti-phosphoTrkB, anti-TrkB, anti-mouse PTP1B and
anti-SHP2 antibodies are shown. Data are represented as mean ±
SEM (n=3 for each group, #p=0.067, Student’s t test).
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Figure 2.4 continued
(A) Purified, active, recombinant GST-fusion proteins (GST only
control, WT and D181A:Y46F PTP1B) (10 µg) were incubated with
BDNF-stimulated (50 ng/ml, 5 minutes) (left panel lanes 1-3,
respectively) or unstimulated (right panel lanes 1-3, respectively)
SH-SY5Y-TrkB cell lysates (1.5 mg) in a substrate trapping (GST
pull-down) experiment. Additionally, D181A:Y46F PTP1B (10 µg) was
incubated with BDNF-stimulated (50 ng/ml, 5 minutes) SH-SY5Y-
TrkB cell lysate (1.5 mg) in the presence of sodium orthovanadate
(left panel lane 4) and with BDNF-stimulated (50 ng/ml, 5 minutes)
kinase-dead SH-SY5Y-TrkB cell lysates (Y702/706,707F TrkB and
Y706/707F TrkB (left panel lanes 5 and 6, respectively)) (1.5 mg).
Protein complexes were pulled down with glutathione beads and
immunoblotted with anti-phosphoTrkB, anti-TrkB, anti-human
PTP1B, as indicated. Lysates used as input were separately
immunoblotted with anti-phosphoTrkB and anti-TrkB. (B) Purified,
active, recombinant GST-fusion proteins (GST only control, WT
and D181A:Y46F PTP1B) (10 µg) were incubated with BDNF-
stimulated (0.5 µg, 45 minutes) mouse brain tissue lysate (3 mg) in
a substrate trapping (GST pull-down) experiment. Protein
complexes were pulled down with glutathione beads and
immunoblotted with anti-TrkB and anti-GST antibodies, as
indicated.
46

Figure 2.5 continued
(A) Cumulative chow intake (in grams) of 4-5 month old Ptpn1-/-
male mice and wild type littermates at 1, 3, and 6 hours following
BDNF (0.2 µg) or aCSF (vehicle) infusion into the lateral ventricle.
Data are represented as mean ± SEM (n = 10 for wild-type, n = 5
for Ptpn1-/- mice, *p ≤ 0.05, #p = 0.066 compared to vehicle
treatment, one way ANOVA). (B) 24 hour % body weight
suppression (compared to vehicle treatment) of 4-5 month old
Ptpn1-/- male mice and wild type littermates following BDNF (0.2
µg) or aCSF (vehicle) infusion into the lateral ventricle. Data are
represented as mean ± SEM (n = 10 for wild-type, n = 5 for Ptpn1-/-
mice, *p < 0.05 compared to wild type controls, Student’s t test).
(C) Core temperature of 4-5 month old Ptpn1-/- male mice and wild
type littermates following BDNF (0.05 µg) or aCSF (vehicle)
infusion into the lateral ventricle. Data are represented as mean ±
SEM (n = 10 for wild-type, n = 5 for Ptpn1-/- mice, *p ≤ 0.05
compared to vehicle treatment, **p < 0.05 compared to wild type
controls, one way ANOVA).
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Figure 2.6 continued
(A) Representative image of SH-SY5Y-TrkB cells with Veh / BDNF
treatment (left) or PTP1B inhibitor / BDNF treatment (right) at 6
hours post-stimulation (t=6). Arrows point at primary neurites (scale
bar = 80 µm). (B) SH-SY5Y-TrkB cells were pretreated with cell-
permeable, PTP1B-specific inhibitor (compound II (500 nM)) or
vehicle (DMSO) for 5 minutes prior to stimulation with BDNF (25
ng/ml) or vehicle (PBS). Primary neurite outgrowth was assessed
prior to and 2, 4, 6, and 24 hours following BDNF or vehicle
stimulation. Average primary neurite length was quantified using
Image J software (Neuron J plugin). Data are represented as mean ±
SEM, (5 neurites in a representative field were quantified and
averaged for each time point and the experiment was repeated three
times, *p < 0.05 compared to respective vehicle controls and **p <
0.05 PTP1B inhibitor / BDNF treatment compared to Veh / BDNF
treatment, one way ANOVA).
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CHAPTER 3: Ptpn1-/- mice show enhanced adult hypothalamic neurogenesis 
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Abstract 
Neurogenesis, or the birth of new neurons, enhances structural and functional plasticity 
in the adult brain. Recent evidence suggests that adult neurogenesis occurs in the 
hypothalamus, a brain region known to play a key role in the regulation of energy 
homeostasis. Hypothalamic neurogenesis is promoted by trophic factors including the 
brain-derived neurotrophic factor (BDNF), which is strongly implicated in central 
metabolic control. Notably, adult neurogenesis has been shown to be impaired in obesity 
(Lee, Bedont et al. 2012, McNay, Briancon et al. 2012, Lee, Yoo et al. 2014). We 
recently established protein tyrosine phosphatase 1B (PTP1B) as a negative regulator of 
BDNF signaling. PTP1B-deficient mice are lean and resistant to diet-induced obesity, 
possibly due in part to sensitized BDNF signaling. Given the neurogenic and the 
metabolic role of BDNF and the novel finding of PTP1B as a negative regulator of central 
BDNF signaling, we hypothesized that mice lacking PTP1B may have enhanced 
hypothalamic neurogenesis and this may contribute to their lean phenotype. To directly 
test this hypothesis, we examined neurogenesis in whole-body PTP1B-deficient mice 
(Ptpn1-/-) and found that Ptpn1-/- mice have significantly increased BrdU+ cells in the 
hypothalamus as adults, but interestingly not during embryonic development. Ptpn1-/- 
hypothalamus also shows trend towards upregulation of genes implicated in various 
aspects of neurogenesis and neural plasticity. Taken together, this study suggests that 
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Ptpn1-/- mice have enhanced adult hypothalamic neurogenesis which may contribute to 
the overall beneficial metabolic effects of PTP1B-deficiency.  
 
Introduction 
Adult neurogenesis has been convincingly shown to occur in two neurogenic areas of 
the brain: the subventricular zone (SVZ) of the olfactory bulb and the subgranular layer 
of the dentate gyrus of the hippocampus. A growing body of evidence suggests that the 
hypothalamus is another brain region where endogenous neural stem cells can 
proliferate and differentiate into neurons under physiological conditions or through 
external factors, albeit to a lesser extent than the two original neurogenic brain regions 
(reviewed in (Migaud, Batailler et al. 2010)). The ependymal layer of the third ventricle is 
the neurogenic zone in the hypothalamus where local proliferation of the neural 
precursor cells, non-ciliated ependymal cells known as radial glia-like tanycytes, occurs. 
Proliferation in this region is subsequently followed by differentiation and lateral 
migration to the hypothalamic parenchyma (reviewed in (Lee, Bedont et al. 2012, Maggi, 
Zasso et al. 2014)). Following the initial studies reporting the presence of neural 
progenitor cells in the hypothalamus using neurosphere formation in vitro and BrdU 
labeling in vivo, several groups have shown enhancement of proliferative activity in the 
hypothalamus through growth factors and trophic factors including epidermal growth 
factor (EGF), basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor 
(BDNF), ciliary neurotrophic factor (CNTF) and insulin-like growth factor 1 (IGF-1) 
(Pencea, Bingaman et al. 2001, Kokoeva, Yin et al. 2005, Xu, Tamamaki et al. 2005, 
Perez-Martin, Cifuentes et al. 2010, Lee, Bedont et al. 2012, McNay, Briancon et al. 
2012).   
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Majority of the neurons in the hypothalamic nuclei implicated in energy balance 
regulation are born between embryonic days E12 and E16. This is the critical time period 
to study neuronal development in the embryonic hypothalamus (Ishii and Bouret 2012). 
Although the hypothalamic neurons involved in feeding circuits are formed during 
embryonic development, they become structurally and functionally immature until 
second to third week of postnatal life (Bouret, Draper et al. 2004). In fact, there is 
substantial neuronal remodeling in the adult mouse hypothalamus between 4 and 12 
weeks of postnatal life (McNay, Briancon et al. 2012). This is the critical time period to 
study neurogenesis in the adult hypothalamus.    
 
Functional significance of hypothalamic neurogenesis is of interest since the 
hypothalamus is a key brain region implicated in feeding regulation and central control of 
energy balance (reviewed in (Lee and Blackshaw 2012)). Some studies have reported 
that a subset of newly born neurons in the adult hypothalamus are leptin responsive 
(through leptin-induced pSTAT3), express markers of terminally differentiated 
hypothalamic neuronal subtypes such as neuropeptide Y (NPY), agouti-related peptide 
(AGRP) and pro-opiomelanocortin (POMC), and that inhibition of cell proliferation in the 
adult hypothalamus significantly effects food intake, energy expenditure, and body 
weight (Kokoeva, Yin et al. 2005, Xu, Tamamaki et al. 2005, Kokoeva, Yin et al. 2007, 
Pierce and Xu 2010, Lee, Bedont et al. 2012). These findings suggest that the newly 
born neurons in the hypothalamus influence metabolic homeostasis through functional 
integration to the hypothalamic circuitry. Notably, in environmental and genetic rodent 
models of obesity, high-fat diet-induced obesity (DIO) and leptin-deficiency (ob/ob) 
models respectively, neurogenesis in the mediobasal hypothalamic parenchyma is 
significantly reduced and remodeling of the arcuate nucleus of the hypothalamus is 
altered (McNay, Briancon et al. 2012). Interestingly, high-fat diet (HFD)-feeding 
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enhances neurogenesis in the median eminence of the hypothalamus and selective 
inhibition of high-fat diet-induced neurogenesis in this region results in attenuation of 
weight gain through increased energy expenditure (Lee, Bedont et al. 2012). Taken 
together, these data strongly suggest that adult hypothalamic neurogenesis contributes 
to the physiological regulation of food intake and body weight, and is affected by dietary 
influences and metabolic diseases such as obesity (reviewed in (Sousa-Ferreira, de 
Almeida et al. 2014)).  
 
BDNF is a potent neurotrophic factor that has been reported to promote the survival and 
differentiation of progenitor cells to generate new neurons in the SVZ, dentate gyrus, 
and additional brain regions where neurogenesis has not been previously identified, 
including the hypothalamus (Zigova, Pencea et al. 1998, Pencea, Bingaman et al. 2001, 
Bergami, Rimondini et al. 2008, Li, Luikart et al. 2008). Both BDNF and its receptor, 
tropomyosin receptor kinase B (TrkB) play paramount roles in the central regulation of 
energy balance (reviewed in (Rios 2013)). It is likely that BDNF influences energy 
homeostasis partly through its role in neurogenesis and neural plasticity in the 
hypothalamus (reviewed in (Noble, Billington et al. 2011)). 
 
We have recently established protein tyrosine phosphatase 1B (PTP1B) as a novel, 
physiological negative regulator of the BDNF/TrkB signaling pathway (Ozek, Kanoski et 
al. 2014). PTP1B has also been implicated in energy balance regulation. Single 
nucleotide polymorphisms within the human PTPN1 gene are associated with obesity 
and metabolic disorders (reviewed in (Tsou and Bence 2012). Furthermore, mice with 
global PTP1B-deficiency (Ptpn1-/-) are lean and resistant to diet-induced obesity 
(Elchebly, Payette et al. 1999, Klaman, Boss et al. 2000). Notably, mice with central 
nervous system (CNS)-specific PTP1B-deficiency (Nestin-Cre-Ptpn1-/-) recapitulate the 
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metabolic phenotype of Ptpn1-/-mice, suggesting that central PTP1B plays a key role in 
the regulation of energy balance (Bence, Delibegovic et al. 2006). Given BDNF’s role in 
neurogenesis and PTP1B’s role in antagonizing this signaling pathway, we hypothesize 
that PTP1B-deficient mice show enhanced hypothalamic neurogenesis, which may 
contribute to the overall beneficial metabolic phenotype of PTP1B-deficiency.  
 
Materials and Methods 
Animal care. Ptpn1-/- mice were generated and genotyped as previously described 
(Tsou, Zimmer et al. 2012). Ptpn1-/- mice and wild type control littermates (on a 129Sv/J 
x C57BL/6 background) were maintained in a temperature-controlled barrier facility on a 
12:12 hour light:dark cycle with ad libitum access to water and standard chow diet 
(Purina Rodent Chow 5001). All procedures were approved by the University of 
Pennsylvania Institutional Animal Care and Use Committee (IACUC). 
 
BrdU administration. For adult neurogenesis experiments, chow diet-fed, 10-12 week 
old, male Ptpn1-/- mice and wild type littermates were individually housed and 
administered 100 mg/kg BrdU labeling reagent (Invitrogen) i.p. once per day for four 
consecutive days. On the fifth day, mice were transcardially perfused and the brains 
were removed for histological analysis as described in more detail below. For embryonic 
neurogenesis experiments, chow diet-fed pregnant dams received a single bolus 
injection of BrdU (150 mg/kg, prepared in 0.007N NaOH in 0.9% saline) (Roche) i.p. for 
more efficient labeling on E12. Ptpn1-/- and wild type pups were transcardially perfused 
on P10 and brains were removed for histological analysis.   
 
Histological analysis. Mice of the indicated age were deeply anesthetized with sodium 
pentobarbital (50-100 mg/kg, i.p.) and perfused via transcardial perfusion with 1X 
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Phosphate Buffered Saline (PBS) followed by ice-cold 4% Paraformaldehyde (PFA). 
Tissues were post-fixed overnight at 4 degrees in 4% PFA. 30 µm thick sections through 
the hypothalamus (bregma -1.06 to -2.46) were collected in the coronal plate on a sliding 
microtome. For the antigen retrieval step, sections were incubated in 50% formamide; 
2X saline sodium citrate (SSC) at 65 degrees for 2 hours and then rinsed in 2X SSC at 
room temperature for 5 minutes. For the denaturation step, sections were incubated in 
2N HCl at 37 degrees for 30 minutes and then neutralized in 0.1M boric acid (pH 8.5) at 
room temperature for 10 minutes. Finally, sections were rinsed in 1X PBS at room 
temperature for 15 minutes. After these initial steps, immunofluorescent staining of free-
floating brain sections was adapted from a previous protocol (Banno, Zimmer et al. 
2010). Normal goat serum (Jackson ImmunoResearch) was used as a blocking solution. 
Sections were incubated with rat monoclonal antibody raised against BrdU (abcam, 
ab6326) as primary antibody followed by Cy3-conjugated goat-anti-rat IgG as secondary 
antibody. Sections were visualized using a Nikon Eclipse 80i fluorescent microscope at 
10X magnification and NIS-Elements software. Quantification was performed using 
Image J software (Image-based tool for counting nuclei (ITCN) plugin).  
 
PCR array. Hypothalamus from 8-9 month old, male Ptpn1-/- mice and wild type 
littermates (n=3 for each genotype) was dissected and immediately frozen in liquid 
nitrogen prior to use. Total RNA was extracted using TRIzol (Invitrogen) and further 
purified with the RNeasy kit (Qiagen). cDNA was synthesized from total RNA using the 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) (Tsou, Rak et al. 
2014). Mouse neurogenesis and neural stem cell PCR array (PAMM-404, 
SABiosciences) was carried out according to the manufacturer’s protocol using the RT2 
SYBR Green qPCR Master Mix (SABiosciences) and the Eppendorf Mastercycler® ep 
RealPlex.  
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Statistical analysis. Results are expressed as mean ± SEM. Comparisons between 
groups were made by unpaired 2-tailed Student’s t-test. A p-value of less than 0.05 was 
considered to be statistically significant.   
 
Results 
Ptpn1-/- mice show increased hypothalamic neurogenesis at 10-12 weeks, but not 
during embryonic development.  
In order to test whether Ptpn1-/- mice show enhanced hypothalamic neurogenesis which 
may contribute to the overall beneficial metabolic phenotype of PTP1B-deficiency, 
BrdU+ cells in the hypothalamus of chow diet-fed, 10-12 week old, male Ptpn1-/- mice 
and wild type control littermates were quantified. Although modest, Ptpn1-/- mice display 
a significant increase in the number of BrdU-labeled, newly born cells compared to the 
wild type controls (Figure 1A, B). The majority of the hypothalamic neurons responsible 
for central energy balance regulation are born around E12 (Ishii and Bouret 2012). To 
determine whether there are differences in the birth of hypothalamic neurons responsible 
for central metabolic control, BrdU+ cells (labeled on E12) in the hypothalamus of 10-day 
old, male Ptpn1-/- mice and wild type control littermates were quantified. The number of 
BrdU-labeled, newly born cells during this developmental time window is similar between 
the genotypes (Figure 2A, B).   
 
Ptpn1-/- mice show a trend toward changes in hypothalamic expression of 
neurogenesis- and neural stem cell-related genes.  
To assess whether there are changes in the expression of genes implicated in 
neurogenesis, a mouse neurogenesis and neural stem cell PCR array was performed in 
the hypothalamus of chow diet-fed, 8-9 month old, male Ptpn1-/- mice and wild type 
58  
control littermates. Preliminary studies suggest that Ptpn1-/- mice show a trend toward 
up-regulation in neuronal migration/axon guidance marker genes including Robo, 
Sema4d, Odz1 and neuronal differentiation marker genes including Bdnf, Bmp4, Nrg1. 
Ptpn1-/- mice show a trend toward down-regulation in Notch and Shh signaling-related 
genes including Hey1 and Shh (Table 1). None of the trends reach statistical 
significance due to small sample size (n=3 for each genotype) in this pilot study.  
 
Discussion 
In this study, we sought to determine whether a lack of PTP1B affects neurogenesis in 
the hypothalamus. We show that Ptpn1-/- mice have increased adult hypothalamic 
neurogenesis compared to their wild type littermates with no difference in embryonic 
neurogenesis in the hypothalamus. Moreover, Ptpn1-/- mouse hypothalamus shows a 
trend toward changes in the expression of genes implicated in neurogenesis and neural 
plasticity.  
 
Our data indicate that adult Ptpn1-/- mice have significantly increased BrdU+ cells in the 
hypothalamus compared to the controls. This number, although statistically significant, is 
relatively low. One possible explanation is the low efficiency in our BrdU labeling 
strategy (one i.p. injection per day for four consecutive days) and our BrdU labeling 
reagent. A previous study reported that a higher efficiency in BrdU labeling in the 
hypothalamus is reached when BrdU is administered intracerebroventricularly (i.c.v.), 
compared to the intraperitoneal (i.p.) administration (Kokoeva, Yin et al. 2007). Another 
possibility is the low level of hypothalamic proliferative activity in our experimental time 
window (10-12 weeks). An earlier study indicated substantial turnover in the 
hypothalamic neurons between 4-12 weeks (McNay, Briancon et al. 2012). In the future, 
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it will be useful to study earlier time frames (4-6 and/or 6-8 weeks) when more BrdU+ 
cells may be detected in the hypothalamus. Neurogenesis in the hypothalamus is shown 
to be sexually dimorphic and more active in females compared to males, especially in 
response to high-fat diet feeding (Lee, Yoo et al. 2014). In this study, only chow diet-fed, 
male Ptpn1-/- and wild type mice were used. It will be important to conclude whether 
there are sex-specific differences in adult hypothalamic neurogenesis by studying female 
Ptpn1-/- mice under more challenging dietary conditions such as HFD.  
 
Leptin, apart from being an adipocyte-secreted hormone that acts on the brain to reduce 
food intake and increase energy expenditure, is also an essential factor required for the 
development of hypothalamic projections from the arcuate nucleus of the hypothalamus 
(ARC) to other key hypothalamic nuclei including the paraventricular nucleus of the 
hypothalamus (PVH). Thus, leptin is considered a key trophic signal affecting the 
hypothalamic circuitry mediating energy balance regulation (Bouret and Simerly 2004). 
PTP1B is a known negative regulator of leptin signaling pathway by directly de-
phosphorylating leptin receptor-associated janus kinase 2 (JAK2) (Cheng, Uetani et al. 
2002, Zabolotny, Bence-Hanulec et al. 2002). In the future, rodent models of 
hypothalamic leptin-receptor- and TrkB receptor-deficiency in the absence of PTP1B will 
help determine whether the observed increase in adult hypothalamic neurogenesis in 
Ptpn1-/- mice is due to enhanced BDNF/TrkB signaling.   
 
In this study, we quantified BrdU+ cells in the hypothalamus as a measure of 
hypothalamic neurogenesis. Future studies should focus on co-labeling BrdU+ cells with 
different cell markers (e.g. Dcx, NeuN, Hu C/D, GFAP) to follow the cell fates and further 
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define whether Ptpn1-/- mice exhibit increased neurogenesis and/or gliogenesis. 
Functional integration of the newly born hypothalamic neurons to the existing 
hypothalamic circuitry is still under investigation. Our findings indicate that Ptpn1-/- 
mouse hypothalamus shows a trend toward up-regulation of genes implicated in axon 
pathfinding, progenitor cell proliferation/migration and neuronal maturation, consistent 
with increased neurogenesis, neural plasticity and functional integration (Taniguchi, 
Amazaki et al. 2009, Mahar, Tan et al. 2011, Yeh, Gonda et al. 2014). It will be crucial to 
identify electrophysiological and neurochemical characteristics of the newly born cells in 
the hypothalamus to study their ability to form functional synaptic connections (reviewed 
in (Sousa-Ferreira, de Almeida et al. 2014)). 
  
Previous studies report functional and physiological significance of hypothalamic 
neurogenesis through its contribution to the plastic control of energy homeostasis in 
response to environmental or physical insults (Pierce and Xu 2010, Lee, Bedont et al. 
2012). Ablation of newly born neurons in the hypothalamus pharmacologically through 
mitotic blockers (Kokoeva, Yin et al. 2005) or physically through focal irradiation (Lee, 
Bedont et al. 2012) will be informative in assessing whether enhanced hypothalamic 
neurogenesis plays a significant role in the overall beneficial metabolic phenotype of 
PTP1B-deficiency in response to HFD.   
 
Several genes that are involved in axon guidance and neurite outgrowth show a trend 
toward up-regulation in Ptpn1-/- hypothalamus. Roundabout homolog 1 (Robo1) acts as 
a chemorepellent through its ligand, Slit. Robo1 guides axons ventrally while also 
promoting dendritic outgrowth (Braisted, Ringstedt et al. 2009, Kim, Roesener et al. 
2011). Semaphorin 4d (Sema4d) plays a role in axonal growth cone guidance through its 
receptor, Plexin B1. Sema4d guides migration of gonadotropin hormone-releasing 
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hormone-1 (GnRH-1) in the hypothalamus while also aiding in neuronal migration 
(Giacobini, Messina et al. 2008). Teneurin 1 (Odz1, also known as TCAP-1) regulates 
axonal and neurite outgrowth in the hypothalamus (Al Chawaf, St Amant et al. 2007). 
Bone morphogenetic protein 4 (Bmp4) allows for the formation of a proliferating 
hypothalamic progenitor region through down-regulation of sonic hedgehog (Shh), 
suggesting a role for Bmp4 in cell proliferation and cell fate determination (Manning, 
Ohyama et al. 2006). Ptpn1-/- hypothalamus shows a trend toward down-regulation of 
Shh signaling-related Shh gene and Notch signaling-related hairy and enhancer-of-split 
1 (Hey1) gene. Both Shh and Notch signaling pathways play an important role in 
hypothalamic neuronal differentiation through hypothalamic astrocyte formation and pro-
neural gene inhibition in the hypothalamus, respectively (Alvarez-Bolado, Paul et al. 
2012, Ratie, Ware et al. 2013). Increase in the expression of genes implicated in neurite 
outgrowth, axonal and dendritic branching, neuronal differentiation and migration could 
contribute to the organization of the hypothalamic pathways involved in energy balance 
regulation. This increase could also play a role in the re-wiring/plasticity of the feeding 
circuits in the hypothalamus as a consequence of PTP1B-deficiency.     
 
Taken together, this study demonstrates that adult hypothalamic neurogenesis is 
enhanced in the absence of PTP1B, but the structural and functional role of the newly 
born neurons in the adult hypothalamus of Ptpn1-/- mice still requires further 
investigation.  
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Gene  Fold Change  
Ptpn1-/- : WT 
p-value Up/Down 
Robo1 1.45 0.23 ↑ 
Sema4d 1.35 0.12 ↑ 
Odz1 1.40 0.12 ↑ 
Bdnf 1.37 0.26 ↑ 
Bmp4 1.54 0.07 ↑ 
Nrg1 1.73 0.21 ↑ 
Hey1 -1.28 0.07 ↓ 
Shh -1.86 0.14 ↓ 
 
Table 1 List of up-regulated and down-regulated genes in Ptpn1-/- hypothalamus. 
List of up-regulated and down-regulated genes in the hypothalamus of chow diet-
fed, 8-9 month old, male Ptpn1-/- mice (n=3) compared to wild type controls (n=3), 
with fold differences and p-values.  
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Abstract  
Brain-derived neurotrophic factor (BDNF) and its receptor, tropomyosin receptor kinase 
B (TrkB), play paramount roles in the central regulation of energy balance. Despite the 
substantial body of genetic evidence implicating BDNF- or TrkB-deficiency in human 
obesity, the critical brain region(s) contributing to the endogenous role of BDNF/TrkB 
signaling in metabolic control remain unknown. We assessed the importance of intact 
endogenous hypothalamic or hindbrain TrkB signaling in the central regulation of energy 
balance by generating Nkx2.1-Ntrk2-/- and Phox2b-Ntrk2+/- mice, respectively, and 
comparing metabolic parameters (body weight, adiposity, food intake, energy 
expenditure and glucose homeostasis) under high-fat diet or chow fed conditions. Our 
data show that when fed a high-fat diet, male and female Nkx2.1-Ntrk2-/- mice have 
significantly increased body weight and adiposity that is likely driven by reduced 
locomotor activity and core body temperature. When maintained on a chow diet, female 
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Nkx2.1-Ntrk2-/- mice exhibit an increased body weight and adiposity phenotype more 
robust than in males, which is accompanied by hyperphagia that precedes the onset of a 
body weight difference. In addition, under both diet conditions, Nkx2.1-Ntrk2-/- mice 
show increased blood glucose, serum insulin and leptin levels. Mice with complete 
hindbrain TrkB-deficiency (Phox2b-Ntrk2-/-) are perinatal lethal, potentially indicating a 
vital role for TrkB in visceral motor neurons that control cardiovascular, respiratory, and 
digestive functions during development. Phox2b-Ntrk2+/- heterozygous mice are similar 
in body weight, adiposity and glucose homeostasis parameters compared to wild type 
littermate controls when maintained on a high-fat or chow diet. Interestingly, despite the 
absence of a body weight difference, Phox2b-Ntrk2+/- heterozygous mice exhibit 
pronounced hyperphagia. Taken together, our findings suggest that the hypothalamus is 
a key brain region involved in endogenous BDNF/TrkB signaling and central metabolic 
control and that endogenous hindbrain TrkB likely plays a role in modulating food intake 
and survival of mice. Our findings also show that female mice lacking TrkB in the 
hypothalamus have a more robust metabolic phenotype. 
 
Introduction 
The alarming increase of obesity worldwide has focused attention on the need for 
understanding the physiological mechanisms implicated in energy balance regulation 
(reviewed in (Flegal, Carroll et al. 2012)). In a recent human genome-wide association 
study, the role of the central nervous system in body mass regulation was strongly 
emphasized (Locke, Kahali et al. 2015). A substantial body of evidence has emerged 
demonstrating that brain-derived neurotrophic factor (BDNF) and its receptor, 
tropomyosin receptor kinase B (TrkB), play paramount roles in the central regulation of 
energy homeostasis (reviewed in (Rios 2013, Vanevski and Xu 2013)). Mutations in 
either the human BDNF or NTRK2 genes are associated with obesity accompanied by 
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hyperphagia (Yeo, Connie Hung et al. 2004, Gray, Yeo et al. 2006). Similarly, mice with 
central BDNF-deficiency or TrkB deletion (Kernie, Liebl et al. 2000, Rios, Fan et al. 
2001, Xu, Goulding et al. 2003, Liao, An et al. 2012, Liao, Li et al. 2013) display 
increased body weight and hyperphagia. The hypothalamus and the hindbrain are two 
major regions within the brain that are implicated in BDNF regulation of energy balance 
although both BDNF and TrkB are broadly distributed throughout the central nervous 
system (Yan, Radeke et al. 1997, Yan, Rosenfeld et al. 1997). Notably, previous studies 
have shown that intraparenchymal BDNF administration into the ventromedial (VMH) 
and paraventricular (PVH) nucleus of the hypothalamus (Wang, Bomberg et al. 2007, 
Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2010, 
Wang, Godar et al. 2010, Godar, Dai et al. 2011), or dorsal vagal complex (DVC) and 
nucleus tractus solitarius (NTS, or nucleus of the solitary tract) of the hindbrain 
(Bariohay, Lebrun et al. 2005, Bariohay, Roux et al. 2009, Spaeth, Kanoski et al. 2012), 
reduces food intake and increases energy expenditure in mice. Whether these two brain 
regions are critical sites contributing to the endogenous role of BDNF/TrkB signaling in 
central metabolic control, however, remains largely unknown. We hypothesize that intact 
endogenous TrkB signaling in the hypothalamus and/or the hindbrain is essential for 
central metabolic control. In this study, we show that deletion of TrkB in the 
hypothalamus results in increased body weight, adiposity and impaired glucose 
homeostasis while a reduction of TrkB in the hindbrain results in hyperphagia without 
affecting overall body weight.  
 
Materials and Methods 
Animal care. All animal care protocols and procedures were approved by the University 
of Pennsylvania Institutional Care and Use Committee. Mice were maintained on a 12-h 
light/12-h dark cycle in a temperature controlled barrier facility, with ad libitum access to 
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water and standard chow (Lab Diet 5010, calories provided by protein (28.7%), fat 
(12.7%), and carbohydrate (58.5%)) or custom high-fat diet (HFD) (Teklad TD93075, 
calories provided by protein (21.2%), fat (54.8%), and carbohydrate (24%)) upon 
weaning (3 weeks of age). Age-matched male and female littermates were used for all 
experiments. 
 
Generation of Nkx2.1-Ntrk2-/- and Phox2b-Ntrk2-/- mice. Nkx2.1-Cre and Phox2b-Cre 
transgenic mice were obtained from The Jackson Laboratory (Stock #008661 and 
#016223 respectively, Bar Harbor, ME). Ntrk2fl/fl mice were obtained from Dr. Robert G. 
Kalb (Children’s Hospital of Pennsylvania) and were originally generated in the lab of Dr. 
Rüdiger Klein (Max Planck Institute for Neurobiology) (Minichiello, Korte et al. 1999). 
Genotyping primers for Nkx2.1-Cre, Phox2b-Cre and the floxed Ntrk2 allele were 
previously described (Zhai, Zhou et al. 2011, Tsou, Zimmer et al. 2012). Initially, Nkx2.1-
Cre and Phox2b-Cre mice were crossed with Ntrk2fl/fl mice to generate Nkx2.1-Cre+ : 
TrkB+/fl and Phox2b-Cre+ : TrkB+/fl mice which were then crossed with Ntrk2fl/fl mice to 
generate Nkx2.1-Ntrk2-/- , Nkx2.1-Ntrk2+/- , Phox2b-Ntrk2-/-, Phox2b-Ntrk2+/- mice and 
wild type controls. Cre- : Ntrk2fl/fl, Cre- : Ntrk2+/fl, and Cre-only mice did not show 
differences in body weight and were combined to form the “wild type” control group. All 
mice were on a C57BL/6 background. 
 
Histological analysis. Mice of the indicated age were deeply anesthetized with sodium 
pentobarbital (100 mg/kg, i.p.) and perfused via transcardial perfusion with 1X 
Phosphate Buffered Saline (PBS) followed by ice-cold 4% Paraformaldehyde (PFA). 
Tissues were post-fixed overnight in 4% PFA. 25µm thick sections through the NTS 
(bregma -6.95 to -8.15) were collected using a cryostat. Immunofluorescent staining of 
free-floating brain sections was adapted from a previous protocol (Banno, Zimmer et al. 
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2010). Normal donkey serum (Jackson ImmunoResearch) was used as a blocking 
solution. Sections were incubated with rabbit polyclonal antibody raised against Phox2b 
(25276-1-AP, Proteintech), or goat polyclonal antibody against TrkB (C-14) (sc-11-G, 
Santa Cruz Biotechnology, Inc) as primary antibodies. Cy3-conjugated donkey-anti-
rabbit IgG and Alexa-Fluor 488-conjugated donkey-anti-goat IgG (Jackson 
ImmunoResearch) were used as secondary antibodies. Sections were visualized at the 
Penn Vet Imaging Core using a Nikon E600 microscope at 20X magnification and Roper 
Scientific imaging software. Quantification was performed on five sections of unilateral 
region of interest containing the NTS along the anterior-posterior axis using the multi 
wavelength cell scoring application within the MetaMorph Image Analysis software. 
 
Body composition and food intake. At weaning, mice were fed either a standard chow 
diet or HFD and body weights were assessed weekly. For food intake experiments, mice 
were singly housed and food intake was measured daily for a period of 5 days at the 
indicated age. Body length was measured as nose-rump length at the indicated age. 
Gonadal fat pads were dissected and weighed at the indicated age. Total fat and lean 
mass was measured using NMR (Echo Medical Systems) at the indicated age at the 
Penn IDOM Mouse Phenotyping, Physiology and Metabolism Core. 
 
Energy expenditure measures. Feed efficiency was calculated as grams weight 
gained/grams food consumed over a period of 5 days. Energy expenditure and infrared 
locomotor activity monitoring (through beam breaks along the X axis) during a 24 hour 
period were done using comprehensive laboratory animal monitoring system (CLAMS) 
at the indicated age at the Penn IDOM Mouse Phenotyping, Physiology and Metabolism 
Core. Core body temperature was measured rectally with a thermistor (MicroTherma 2T; 
ThermoWorks) during the light cycle at the indicated age. Serum T4 and T3 levels were 
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measured using a solid phase competitive ELISA (IBL America) in the Penn IDOM 
Radioimmunoassay and Biomarkers Core. White and brown adipose tissue gene 
expression and brown adipose tissue protein levels were measured by real-time PCR 
and immunoblotting, respectively as described below.  
 
Leptin sensitivity experiment. For in vivo leptin sensitivity measurements, recombinant 
mouse leptin 1 μg/g body weight/injection (A. F. Parlow; National Hormone and Peptide 
Program) or 0.9% saline was administered i.p. to male mice on a chow diet at 8 weeks 
of age. Mice were initially injected with saline i.p. every 12 hours over the course of 48 
hours. Leptin was subsequently administered following the same paradigm for 3 days. 
Mice received both saline and leptin injections using a within subjects design. Body 
weight and food intake were monitored daily for the 5 experimental days and for 2 
additional recovery days. Body weight and food intake measurements for the days 
before the start of leptin injections were averaged and used to calculate percent change 
from baseline.  
 
HPA axis responsivity. HPA axis responsivitiy was performed in singly housed male 
mice at the indicated age. Plasma corticosterone was measured following an acute 15 
minute restraint in a 50mL conical tube. Tail blood was collected in EDTA-serum tubes 
before and after the restraint (0 and 15 minutes, respectively) and 15 minutes and 75 
minutes after the end of the restraint (30 and 90 minutes, respectively). Serum 
corticosterone levels were measured as described previously (Tsou, Rak et al. 2014) 
 
Glucose homeostasis and serum analysis. A glucose tolerance test (GTT) was 
performed in male mice at the indicated age as described previously (Klaman, Boss et 
al. 2000). Blood glucose was assayed in tail blood using a glucometer (Contour, Bayer). 
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Random-fed or overnight fasted serum insulin and leptin levels were measured at the 
indicated age as described previously (Tsou, Rak et al. 2014). Liver triglyceride and 
cholesterol analyses were done at the Vanderbilt Hormone Assay and Analytical 
Services Core as described previously (Delibegovic, Zimmer et al. 2009). 
 
Real-time PCR. Total RNA was extracted using TRIzol (Invitrogen) and further purified 
with the RNeasy kit (Qiagen). cDNA was synthesized from total RNA using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Quantitative real-time 
PCR (RT-PCR) was carried out using RT2 SYBR Green qPCR Master Mix 
(SABiosciences) and samples were run using the Eppendorf Mastercycler® ep 
RealPlex. The relative mRNA expression was calculated using the comparative 
threshold cycle method as previously described (Tsou, Rak et al. 2014). The house 
keeping gene Hprt1 was used as an internal control. Primers used for real-time PCR 
were as follows (also see Appendix A):  
Mc4r (PPM34139A, SABiosciences),  
Pparg (PPM05108C, SABiosciences),  
Actinb (PPM02945B, SABiosciences).  
 
Immunoblotting. Brain tissues were dissected and immediately frozen in isopentane 
prior to use. NTS-enriched DVC were collected using a cryostat by targeted 
micropunches (bregma: − 7.76 mm, punch depth 1.0 mm) extending rostrally. Tissues 
were homogenized in RIPA buffer (10 mM Tris-HCl, pH 7.4, 150 mM sodium chloride, 
0.1 % SDS, 1 % Triton X-100, 1 % sodium deoxycholate, 5 mM EDTA,1 mM sodium 
fluoride) with protease inhibitor cocktail (Roche, 1:100 dilution), and sodium 
orthovanadate (2 mM). Protein concentrations were determined using a BCA Protein 
Assay (Thermo Scientific). Immunoblotting was done as described previously (Banno, 
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Zimmer et al. 2010). Antibodies used for immunoblotting were the following: Trk (C-14) 
(sc-11, Santa Cruz Biotechnology, Inc), SH-PTP2 (C-18) (sc-280, Santa Cruz 
Biotechnology, Inc), Ucp1 (ab10983, Abcam), β-actin (4967, Cell Signaling). Blots were 
quantified using ImageJ software. 
 
Statistical analysis. Results are expressed as mean ± SEM. Comparisons between 
groups were made by unpaired 2-tailed Student’s t-test, 1-way ANOVA or 2-way ANOVA 
followed by Bonferroni posttest, as appropriate. A p-value of less than 0.05 was 
considered to be statistically significant.  
 
Results 
Nkx2.1-Ntrk2-/- mice display increased body weight, adiposity and body length on 
HFD. 
In order to generate mice with TrkB-deficiency throughout the hypothalamus, Ntrk2fl/fl 
mice were crossed to a line of transgenic Nkx2.1-Cre mice which express Cre in the 
ventral forebrain, including the majority of the hypothalamus, but not in caudal brain 
regions such as the hindbrain (Ring and Zeltser 2010). In the Ntrk2fl/fl mice, the floxed 
exon is within the tyrosine kinase domain of the TrkB receptor resulting in deletion of the 
full length TrkB isoform when recombined (Minichiello, Korte et al. 1999).  As expected, 
Nkx2.1-Ntrk2-/- mice show significant reduction of total TrkB protein in the hypothalamus 
but not the rest of the brain (Figure 1A,B). Weekly body weights of male and female 
Nkx2.1-Ntrk2-/- mice were examined and compared with the Nkx2.1-Ntrk2+/- 
heterozygous mice and wild type control littermates upon weaning. When fed a HFD, 
both male (Figure 1C) and female (Figure 1D) Nkx2.1-Ntrk2-/- mice display significantly 
increased body weight compared to their wild type littermates, with the females showing 
a greater increase compared to controls. Nkx2.1-Ntrk2+/- heterozygous male mice are 
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similar in body weight compared to the Nkx2.1-Ntrk2-/- male mice. To determine whether 
the increase in body weight reflects changes in adiposity, body composition was 
assessed by NMR in males and gonadal fat was weighed in females. Male Nkx2.1-
Ntrk2-/- mice display significant increases in both fat mass (Figure 1E,F) and lean mass 
(Figure 1G). Female Nkx2.1-Ntrk2-/- mice also have significantly increased adiposity as 
measured by gonadal fat weight (Figure 1H). Consistent with the increased adiposity, 
Nkx2.1-Ntrk2-/- mice exhibit increased serum leptin levels under both fed and fasted 
conditions (Table 1). Both male (Figure 1I) and female (Figure 1J) Nkx2.1-Ntrk2-/- mice 
show concomitant increases in body length.  
 
Nkx2.1-Ntrk2-/- mice show no difference in food intake on HFD but display 
decreased activity and core temperature. 
In order to determine the cause of the increased body weight and adiposity of the 
Nkx2.1-Ntrk2-/- mice on HFD, daily food intake was measured for a period of five days 
and the mice were also placed in CLAMS metabolic cages to directly measure energy 
expenditure and locomotor activity. These analyses were performed at 5-6 weeks of age 
prior to the onset of any body weight difference. Nkx2.1-Ntrk2-/- mice do not show 
changes in high-fat diet intake at this age compared to their wild type littermates (Figure 
2A). Interestingly, Nkx2.1-Ntrk2-/- mice exhibit increased feed efficiency (∆body weight / 
∆food intake) suggesting that they have energy expenditure impairments (Figure 2B). 
While VO2, VCO2 and RER are similar in Nkx2.1-Ntrk2-/- and control mice (Figure 2E-G), 
Nkx2.1-Ntrk2-/- mice show reduced locomotor activity (Figure 2C) and reduced core 
temperature (Figure 2D). No difference in serum T4 or T3 levels is detected (Table 1). 
Baseline and stress-induced serum corticosterone levels are also similar (Supplemental 
1A). 
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To assess whether there are changes in gene expression consistent with the metabolic 
impairments observed in Nkx2.1-Ntrk2-/- mice on HFD, anorexigenic pro-
opiomelanocortin (Pomc) and orexigenic neuropeptide y (Npy) and agouti-related 
peptide (Agrp) neuropeptide mRNA levels were measured in the hypothalamus of 
Nkx2.1-Ntrk2-/- mice and wild type controls. Consistent with their obese phenotype, 
Pomc gene expression is significantly lower in Nkx2.1-Ntrk2-/- mice compared to 
controls. Npy and Agrp expression levels are not different between the genotypes 
(Figure 3A). No changes in LepR or Mc4R expression are detected between Nkx2.1-
Ntrk2-/- mice and wild type controls (Figure 3A). A significant reduction in the expression 
of genes implicated in thermogenesis and brown adipose determination, including Ucp1, 
Cidea and Pgc1α, in WAT of Nkx2.1-Ntrk2-/- mice is consistent with impaired WAT 
browning (Figure 3B). Consistent with the elevated body weight and reduced core 
temperature, Ucp1 mRNA (data not shown) and Ucp1 protein (Figure 3C) are 
significantly lower in BAT of Nkx2.1-Ntrk2-/- mice. Nkx2.1-Ntrk2-/- mice also have 
significantly increased liver triglycerides (Figure 3D,E for males and females, 
respectively) while liver cholesterol levels are similar (1.6 ± 0.2 for wild type males, 1.7 ± 
0.1 for Nkx2.1-Ntrk2-/- males; 2.0 ± 0.1 for wild type females, 2.5 ± 0.3 for Nkx2.1-Ntrk2-
/- females).     
 
Nkx2.1-Ntrk2-/- mice display increased body weight, adiposity and body length on 
chow diet. 
Weekly body weights of male and female Nkx2.1-Ntrk2-/- mice were examined and 
compared with the Nkx2.1-Ntrk2+/- heterozygous mice and wild type control littermates 
upon weaning. When maintained on a chow diet, male Nkx2.1-Ntrk2-/- mice are similar 
in body weight to their wild type littermates (Figure 4A) whereas female Nkx2.1-Ntrk2-/- 
mice show significantly increased body weight (Figure 4B). Despite the absence of a 
75 
 
body weight phenotype, male Nkx2.1-Ntrk2-/- mice display a significant increase in fat 
mass (Figure 4C,D). Lean mass is similar between male Nkx2.1-Ntrk2-/- and control 
mice (Figure 4E). Female Nkx2.1-Ntrk2-/- mice also have significantly increased 
adiposity, as measured by gonadal fat weight (Figure 4F). Both male (Figure 4G) and 
female (Figure 4H) Nkx2.1-Ntrk2-/- mice display a slight increase in body length.  
 
Nkx2.1-Ntrk2-/- mice show increased food intake and leptin resistance. 
In order to determine the cause of the increased body weight and adiposity of the 
Nkx2.1-Ntrk2-/- mice on chow, daily food intake was measured for a period of five days 
prior to the onset of any body weight difference. In contrast to mice maintained on HFD, 
chow-fed Nkx2.1-Ntrk2-/- female mice display hyperphagia prior to a significant body 
weight difference (Figure 5A). Nkx2.1-Ntrk2-/- female mice also exhibit increased feed 
efficiency (Figure 5B), suggesting that both food intake and energy expenditure 
impairments likely play a role in the overall body weight phenotype. In response to 
exogenous leptin administration, Nkx2.1-Ntrk2-/- mice show resistance to leptin-induced 
suppression of food intake (Figure 5C) suggesting that intact hypothalamic TrkB 
signaling is required to convey leptin’s effects on feeding. With this dose and injection 
paradigm, there is no significant reduction in body weight in either group (Figure 5D).  
 
Nkx2.1-Ntrk2-/- mice show impaired glucose homeostasis. 
Given that obesity is often accompanied by glucose intolerance and insulin resistance, 
blood glucose and serum insulin levels were measured under random fed or overnight 
fasted conditions in male and female Nkx2.1-Ntrk2-/- mice and controls fed a chow diet 
or HFD. Overall, female Nkx2.1-Ntrk2-/- mice show a more severe hyperglycemic and 
hyperinsulinemic phenotype compared to male Nkx2.1-Ntrk2-/- mice and the phenotype 
is more robust on HFD compared to chow (Table 1,2). Prior to the onset of major body 
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weight differences, Nkx2.1-Ntrk2-/- mice have similar blood glucose and serum insulin 
levels (data not shown) to the controls. Male Nkx2.1-Ntrk2-/- mice which do not have a 
body weight phenotype on chow also do not display any impairment in glucose tolerance 
test (Table 2, Supplemental 1B). Taken together, these results suggest that the 
impairments in glucose metabolism that are detected in Nkx2.1-Ntrk2-/- mice on both 
diets are likely secondary to the body weight gain.  
 
Phox2b-Ntrk2-/- mice are perinatal lethal. 
In order to assess the importance of endogenous hindbrain TrkB receptors to overall 
energy balance, mice with hindbrain TrkB-deficiency were generated by crossing Ntrk2 
fl/fl mice to a line of transgenic Phox2b-Cre mice which express Cre in the NTS and 
DVC of the hindbrain but not in the hypothalamus (Scott, Williams et al. 2011). Notably, 
despite being born in expected Mendelian ratios (data not shown), Phox2b-Ntrk2-/- mice 
die within 2-3 weeks of postnatal life. Phox2b-Ntrk2-/- mice are noticeably smaller 
(Figure 6A) and weigh significantly less (8.85g ± 0.14 for wild type (n=24); 5.02g ± 0.14 
for Phox2b-Ntrk2-/- (n=13), measured at P18) than their wild type control littermates. 
Immunohistochemistry studies show significant overlap of Phox2b+ and TrkB+ cells in 
the NTS of wild type mice (62.9% ± 9.7 of Phox2b+ cells are also TrkB+), and confirm 
that the Phox2b-Ntrk2-/- mice lack TrkB expression in Phox2b+ neurons (Figure 6B). 
Phox2b mRNA levels in the NTS are similar between Phox2b-Ntrk2-/- and wild type 
controls (data not shown). Phox2b-Ntrk2+/- heterozygous mice have an approximately 
40% reduction in TrkB protein within the NTS compared to wild type controls as 
assessed by immunoblotting of NTS-enriched tissue punches (Figure 6C,D).  
 
Phox2b-Ntrk2+/- mice are hyperphagic in the absence of a body weight phenotype. 
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Phox2b-Ntrk2+/- mice and wild type controls were weaned onto either HFD or chow diet. 
When maintained on HFD, Phox2b-Ntrk2+/- female and male mice are similar in body 
weight compared to their wild type littermates (Figure 6E for females, Supplemental 2A 
for males). Adiposity is also similar, as measured by gonadal fat weight (Figure 6F for 
females, Supplemental 2B for males), as is body length (Figure 6G for females, 
Supplemental 2C for males). Interestingly, despite the absence of a body weight 
difference, cumulative and average daily food intake measurements suggest that 
Phox2b-Ntrk2+/- mice are hyperphagic (Figure 7A,B). Phox2b-Ntrk2+/- mice are similar 
to their wild type littermates in body temperature (Figure 7C) and BAT Ucp1 gene 
expression (Figure 7D). On chow diet, there are no differences in body weight 
(Supplemental 3A,B for males and females, respectively), adiposity (Supplemental 3C,D 
for males and females, respectively) or body length (Supplemental 3E,F for males and 
females, respectively). Phox2b-Ntrk2+/- mice still display increased food intake, albeit to 
a lesser extent than on HFD (Supplemental 3G,H for cumulative and average daily food 
intake, respectively). Blood glucose and serum insulin levels are normal in Phox2b-
Ntrk2+/- mice on either diet, with the exception of increased fasted blood glucose on 
chow-fed Ntrk2+/- male mice (Table 3).  
 
Discussion 
BDNF and TrkB are known to play a major role in the central regulation of energy 
homeostasis and are also implicated in human obesity. Despite compelling evidence 
from rodent models to date emphasizing the role of BDNF/TrkB signaling in central 
metabolic control, the requirement of endogenous regional TrkB signaling is still not 
established. In this study, we have generated two mouse models of TrkB-deficiency to 
assess the role of intact endogenous hypothalamic (Nkx2.1-Ntrk2-/-) or hindbrain 
(Phox2b-Ntrk2-/-) TrkB signaling in energy balance regulation. Our data clearly 
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demonstrate that Nkx2.1-Ntrk2-/- mice display significantly increased body weight and 
adiposity while Phox2b-Ntrk2+/- mice are hyperphagic without alterations in body weight 
or adiposity.  
 
Both male and female Nkx2.1-Ntrk2-/- mice show significantly increased body weight 
when maintained on HFD although the females have a more severe metabolic 
phenotype compared to males. Furthermore, only females display significantly increased 
body weight when maintained on regular rodent chow diet. These findings are consistent 
with previous studies showing that female mice with BDNF- or TrkB-deficiency exhibit a 
more robust metabolic phenotype than males (Xu, Goulding et al. 2003, Liao, Li et al. 
2013). These sex-specific differences suggest sexual dimorphism of the hypothalamic 
TrkB signaling pathway, which has been previously shown in other brain regions (Liu, 
Rutlin et al. 2012, Lucas, Jegarl et al. 2014). For example, there is an estrogen response 
element within the BDNF gene (Sohrabji, Miranda et al. 1995) and estrogen signaling 
has been reported to induce BDNF expression in the hippocampus (Solum and Handa 
2002).  In a reciprocal manner, TrkB signaling has been reported to potentiate estrogen-
initiated signaling in the human neuronal SH-SY5Y cells (Wong, Woon et al. 2011). Both 
BDNF and estrogen influence synaptic plasticity by promoting dendritic spine growth 
(Scharfman and MacLusky 2006) and there is overlap between estrogen receptor-
expressing cells and cells that express BDNF and TrkB in the brain (Solum and Handa 
2002). The more severe metabolic phenotype in female Nkx2.1-Ntrk2-/- mice could be 
due to TrkB-deficiency within the VMH where estrogen receptor alpha, BDNF and TrkB 
are all highly expressed; if TrkB signaling is absent, estrogen signaling may be blunted 
leading to increased weight gain. Furthermore, using a BDNF-mimetic to target muscular 
TrkB receptors results in improvements in energy expenditure and overall reduction in 
body weight only in female mice, suggesting there may be interactions between sex 
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hormones and BDNF/TrkB pathways in peripheral tissues in addition to brain (Chan, Tse 
et al. 2015). Although we did not find differences in estrogen receptor alpha gene 
expression in the whole hypothalamus of Nkx2.1-Ntrk2-/- mice and wild type controls 
(data not shown), further investigation is required to study the interaction between 
estrogen and BDNF/TrkB signaling within specific nuclei of the hypothalamus. 
 
In addition to the sex-specific differences, there are differences in various parameters of 
the metabolic phenotype of Nkx2.1-Ntrk2-/- mice depending on the diet. Somewhat 
surprisingly, under HFD-fed conditions Nkx2.1-Ntrk2-/- mice do not show any differences 
in food intake while chow-fed Nkx2.1-Ntrk2-/- mice exhibit hyperphagia. It is possible that 
the HFD-fed mice reach a “ceiling effect” in HFD consumption due to the high palatability 
of this diet. Alternatively, very high levels of circulating leptin in HFD-fed Nkx2.1-Ntrk2-/- 
mice might counteract the hyperphagia by suppressing food intake. On HFD, the overall 
body weight phenotype appears to be primarily driven by decreased energy expenditure, 
specifically reduced locomotor activity and decreased core temperature. Direct 
administration of BDNF into the VMH or PVH results in increased spontaneous physical 
activity (Wang, Bomberg et al. 2010, An, Liao et al. 2015) and BDNF delivered to PVH 
results in increased BAT Ucp1 gene expression through sympathetic innervation (Wang, 
Bomberg et al. 2007). Thus, the observed reduction in activity and core temperature is 
consistent with deletion of TrkB in these two brain regions. There are no differences in 
measures of indirect calorimetry at week 5-6 but this does not rule out the possibility of 
Nkx2.1-Ntrk2-/- mice developing reduced basal metabolic rate at a later time point, 
which will require further study. A previous paper which examined mice with central 
TrkB-deficiency using the Rgs9-Cre which deletes in the arcuate nucleus (ARC), 
dorsomedial nucleus of the hypothalamus (DMH), and lateral hypothalamus (LH) (Liao, 
Li et al. 2013) reported similar increases in body weight and adiposity. However, Rgs9-
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Ntrk2-/- mice do not show reduced locomotor activity while Nkx2.1-Ntrk2-/- mice do. 
Additionally Rgs9-Ntrk2-/- mice, unlike Nkx2.1-Ntrk2-/- , show increased VO2 production 
and VCO2 consumption. One explanation for this discrepancy between the two lines could 
be that with the Rgs9-Cre line, the PVH and VMH are not targeted efficiently and there is 
additional deletion in the striatum, cortex and hippocampus (Liao, Li et al. 2013). Chow-
fed male Rgs9-Ntrk2-/- mice have significantly increased body weight compared to the 
controls and Nkx2.1-Ntrk2-/- do not. This difference is likely due to the variation in caloric 
makeup of the chow diet as the diet used in that study has an intermediate fat 
percentage (21.6% fat by calories) between the chow diet (12.7% fat by calories) and 
HFD (54.8% fat by calories) used in this study.  
 
In the current study, we find that Nkx2.1-Ntrk2-/- mice exhibit increased linear growth, 
similar to previously described mouse models of BDNF-deficiency and TrkB 
hypomorphic mice (Kernie, Liebl et al. 2000, Rios, Fan et al. 2001), implicating the 
BDNF/TrkB signaling pathway in growth regulation. The melanocortin pathway also 
plays an important role in somatic growth (Yen, Gill et al. 1994, Ring and Zeltser 2010), 
although we did not detect any differences in Mc4r gene expression in the hypothalamus 
of Nkx2.1-Ntrk2-/- mice compared to controls. Nevertheless, it is possible that TrkB-
deficiency results in impaired melanocortin signaling and increased linear growth 
indirectly via this pathway. 
 
The increased body weight phenotype in Nkx2.1-Ntrk2-/- mice is accompanied by 
glucose homeostasis impairments as these mice are hyperglycemic and 
hyperinsulinemic. Notably, at an earlier time point (8-10 weeks of age) there are no 
significant differences in fed or fasted blood glucose and serum insulin levels (data not 
shown), suggesting that this phenotype may most likely be secondary to increased body 
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weight. Consistently, Nkx2.1-Ntrk2-/- male mice on chow diet which do not have a body 
weight phenotype also do not display impairments in glucose homeostasis, as measured 
by fed and fasted blood glucose, serum insulin levels and glucose tolerance test. The 
increased fed (but not fasted) blood glucose levels in chow-fed Nkx2.1-Ntrk2-/- female 
mice could be due to hyperphagia.   
 
BDNF is a key neurotrophic factor that is implicated in neural circuit development and 
plasticity through enhancing axonal arborization and neurite outgrowth (Jeanneteau, 
Deinhardt et al. 2010, Park and Poo 2013). BDNF has also been shown to influence 
neurohormone synthesis, differentiation and release in the hypothalamus (Tapia-
Arancibia, Rage et al. 2004). Nissl staining of the Nkx2.1-Ntrk2-/- hypothalamus does 
not reveal a major difference in the overall hypothalamic architecture (data not shown) 
suggesting that the metabolic phenotype of the Nkx2.1-Ntrk2-/- mice is not a result of 
gross neuroanatomical abnormalities due to embryonic deletion of TrkB (starting at E10) 
in the hypothalamus. However, given that BDNF has potent neurotrophic effects, we 
cannot rule out the possibility that TrkB-deficiency within the hypothalamus results in 
altered neuronal connectivity. In fact, a recent study reported that BDNF-deficient mice 
exhibit impairments in NPY/AGRP projections from the ARC to the PVH as well as 
impaired POMC projections to the DMH (Liao, Bouyer et al. 2015). In the future, it will be 
very informative to perform neuronal tracing experiments in mouse models of TrkB-
deficiency restricted to distinct subpopulations of neurochemically identified neurons to 
test whether absence of TrkB in these neuronal populations result in impairments in 
intrahypothalamic projections similar to BDNF-deficient mice.    
 
Studies show that Nkx2.1 is broadly expressed in the hypothalamus. Within the ARC, 
cells that express Nkx2.1 give rise to a subset of GABAergic, NPY, POMC and 
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dopaminergic neurons or glia (tanycytes) (Xu, Tam et al. 2008). Interestingly, a recent 
study has shown that in the arcuate nucleus, most of the TrkB+ neurons do not express 
POMC or NPY, suggesting that they represent a distinct set of previously 
uncharacterized neurons (Liao, Bouyer et al. 2015). In the future, it will be very 
informative to identify the neurochemical characteristics of the TrkB-expressing neurons 
in the hypothalamus to further elucidate their role in the hypothalamic circuitry controlling 
energy balance.    
 
Previous studies have shown that hypothalamic BDNF expression is regulated by 
melanocortin signaling, that BDNF acts downstream of melanocortin signaling to 
regulate food intake and body weight, and that BDNF is required for leptin to activate 
hypothalamic neurons and to inhibit food intake (Xu, Goulding et al. 2003, Liao, An et al. 
2012). Our data show that although there are no changes in the expression of leptin 
receptor (LepR) and melanocortin 4 receptor (Mc4R) genes in the whole hypothalamus, 
Nkx2.1-Ntrk2-/- mice are resistant to acute leptin-induced suppression of food intake. 
Thus, these findings support the notion that BDNF/TrkB signaling is an important effector 
in conveying leptin’s effects on feeding.  
 
Phox2b-Ntrk2-/- mice are perinatal lethal within second to third postnatal week of life 
despite being born in appropriate Mendelian ratios. We speculate that this is due to the 
vital role of TrkB signaling in the development of visceral motor neurons in the brainstem 
that are implicated in cardiovascular, respiratory and digestive functions (Pattyn, Morin 
et al. 1999, Coppola, d'Autreaux et al. 2010). In the future, it will be crucial to use an 
inducible Cre line to overcome the lethal phenotype and to study the role of endogenous 
hindbrain TrkB in central metabolic control.  
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Consistent with the notion that hindbrain TrkB signaling is important to food intake 
regulation (Spaeth, Kanoski et al. 2012), Phox2b-Ntrk2+/- mice exhibit hyperphagia in 
the absence of a body weight phenotype. Whether these animals have increased energy 
expenditure to counteract the increased food intake similar to mice with hindbrain LepR 
deletion (Scott, Williams et al. 2011) needs further investigation. Hyperphagia observed 
in both HFD and to a lesser extent chow diet-fed Phox2b-Ntrk2+/- mice could be due to 
local action of BDNF/TrkB signaling in the NTS and DVC or through alterations in the 
forebrain-hindbrain wiring, likely through the PVH (reviewed in (Grill and Hayes 2012)) or 
through projections to the mesolimbic reward centers involved in hedonic feeding 
(Cordeira, Frank et al. 2010). Phox2b is expressed in enteric neuronal precursors that 
migrate from the vagal neural axis in a rostrocaudal manner to innervate the stomach 
and the intestine, and differentiate into enteric neurons (Pattyn, Morin et al. 1997, 
Young, Hearn et al. 1998). In Phox2b-/- mice, enteric neuronal precursors fail to migrate 
from foregut to midgut and hindgut due to increased apoptosis (Pattyn, Morin et al. 
1999). Notably, both BDNF and TrkB are expressed in the enteric nervous system 
innervating the gut. BDNF enhances enteric nervous system signaling by promoting 
neural activity and synaptic transmission and subsequently increasing gastrointestinal 
motility (Boesmans, Gomes et al. 2008). Furthermore, Ntrk2-/- mice show deterioration 
of the normal architecture of the enteric nervous system (Levanti, Esteban et al. 2009). 
Both BDNF and TrkB expression are altered in intestinal pathologies such as 
Hirschprung disease and infantile hypertrophic pyloric stenosis (Hoehner, Wester et al. 
1996, Guarino, Yoneda et al. 2001). Thus, it is feasible that impairments resulting from a 
lack of TrkB in the enteric nervous system of Phox2b-Ntrk2+/- mice could lead to a 
deficiency in intestinal nutrient absorption and subsequent hyperphagia in the absence 
of body weight differences. 
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Taken together, our study establishes the importance of the hypothalamus as a key 
brain region in endogenous BDNF/TrkB signaling and central metabolic control and 
emphasizes that endogenous hindbrain BDNF/TrkB signaling has a modulatory role in 
food intake. 
 
Appendix A.  
Gene  Forward primer Reverse primer 
Pomc 5’ GACACGTGGAGATGCCGAG 3’ 5’ CAGCGAGAGGTCGAGTTTGC 3’ 
Agrp 5’ GCGGAGGTGCTAGATCCACA 3’ 5’ AGGACTCGTGCAGCCTTACAC 3’ 
Npy 5’ CTCCGCTCTGCGACACTACA 3’ 5’ AATCAGTGTCTCAGGGCTGGA 3’ 
Leprb 5’ CAAACCCCAAGAATTGTTCCTGG 3’ 5’ TCAGGCTCCAGAAGAAGAGGACC 3’ 
Hprt1 5’ GCGTCGTGATTAGCGATGATGAAC 3’ 5’ CCTCCCATCTCTCCTTCATGCATCT 3’ 
Ucp1 5’ GGCATTCAGAGGCAAATCAGCT 3’ 5’ CAATGAACACTGCCACACCTC 3’ 
Cidea 5’ ATCACAACTGGCCTGGTTACG 3’ 5’ TACTACCCGGTGTCCATTTCT 3’ 
Elovl3 5’ GGACCTGATGCAACCCTATGA 3’ 5’ TCCGCGTTCTCATGTAGGTCT 3’ 
Ppargc1a 5’ CCCTGCCATTGTTAAGACC 3’ 5’ TGCTGCTGTTCCTGTTTTC 3’ 
Prdm16 5’ CAGCACGGTGAAGCCATTC 3’ 5’ GCGTGCATCCGCTTGTG 3’ 
  

Figure 4.1 continued
(A) TrkB protein levels in the hypothalamus (top 2 blots) and brain
(bottom 2 blots) of Nkx2.1-Ntrk2-/- (KO) mice compared with Nkx2.1-
Ntrk2+/- (Het) and Cre- controls (WT). SHP2 protein levels are shown as
a loading control. (B) Blots are quantified using ImageJ software, n=4
for each genotype. (C) Body weights of male Nkx2.1-Ntrk2-/- (n=11),
Nkx2.1-Ntrk2+/- (n=10) and wild type controls (n=19) on HFD. (D) Body
weights of female Nkx2.1-Ntrk2-/- (n=13), Nkx2.1-Ntrk2+/- (n=5) and wild
type controls (n=26) on HFD. (E) Fat mass and (F) % fat mass
normalized to body weight as determined by NMR of male Nkx2.1-
Ntrk2-/- (n=6), Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6). (G)
Lean mass as determined by NMR of male Nkx2.1-Ntrk2-/- (n=6),
Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6). (H) Gonadal fat
weight of female Nkx2.1-Ntrk2-/- (n=7), Nkx2.1-Ntrk2+/- (n=5), and wild
type controls (n=6). (I) Body length for male Nkx2.1-Ntrk2-/- (n=6),
Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6). (J) Body length for
female Nkx2.1-Ntrk2-/- (n=7), Nkx2.1-Ntrk2+/- (n=5), and wild type
controls (n=6). All values are mean ± SEM. Weight curves are analyzed
by two-way ANOVA followed by Bonferroni post-hoc pairwise
comparison between Nkx2.1-Ntrk2-/- mice and wild type controls. Body
composition and body length data are analyzed by one-way ANOVA
followed by Bonferroni post-hoc pairwise comparison with the wild
type controls. *p<0.05, #p<0.10 compared to wild type.
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Figure 4.2 continued
(A) Cumulative food intake of 5-6 week old, female Nkx2.1-Ntrk2-/-
(n=6) mice and wild type controls (n=6) on HFD. (B) 5 day feed
efficiency of 5-6 week old, female Nkx2.1-Ntrk2-/- (n=6) mice and
wild type controls (n=6). (C) Locomotor activity of 5-6 week old,
female Nkx2.1-Ntrk2-/- (n=5) mice and wild type controls (n=5). (D)
Core temperature of 5-6 week old, female Nkx2.1-Ntrk2-/- (n=6) mice
and wild type controls (n=6). (E) Oxygen consumption, (F) Carbon
dioxide production, (G) Respiratory exchange ratio (RER) of 5-6
week old, female Nkx2.1-Ntrk2-/- (n=5) mice and wild type controls
(n=5). All values are mean ± SEM. Cumulative food intake is
analyzed by two-way ANOVA followed by Bonferroni post-hoc
pairwise comparison between Nkx2.1-Ntrk2-/- mice and wild type
controls. Feed efficiency and energy expenditure measures are
analyzed by unpaired two-tailed Student’s t-test *p<0.05 compared
to wild type.
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Figure 4.3 Nkx2.1-Ntrk2-/- mice show changes in gene expression
consistent with their metabolic impairments on HFD. (A) Expression of
Pomc, Agrp, Npy, LepR, Mc4R in the hypothalamus of female Nkx2.1-Ntrk2-
/- (n=6) mice and wild type controls (n=5). Hprt1 is used as a housekeeping
gene. (B) Expression of Ucp1, Cidea, Elovl3, Pgc1a, Prdm16, Pparg in the
WAT of female Nkx2.1-Ntrk2-/- (n=6) mice and wild type controls (n=6).
Hprt1 is used as a housekeeping gene. (C) Ucp1 protein levels in the BAT
of female Nkx2.1-Ntrk2-/- (n=6) mice and wild type controls (n=6). Beta-
actin protein levels are used as loading control. (D) Liver triglyceride levels
of male Nkx2.1-Ntrk2-/- (n=6) mice and wild type controls (n=6). (E) Liver
triglyceride levels of female Nkx2.1-Ntrk2-/- (n=6) mice and wild type
controls All values are mean ± SEM. All measures are analyzed by unpaired
two-tailed Student’s t-test *p<0.05.
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Figure 4.4 continued
(A) Body weights of male Nkx2.1-Ntrk2-/- (n=10), Nkx2.1-Ntrk2+/-
(n=7) and wild type controls (n=20) on chow. (B) Body weights of
female Nkx2.1-Ntrk2-/- (n=6), Nkx2.1-Ntrk2+/- (n=12) and wild type
controls (n=23) on chow. (C) Fat mass and (D) % fat mass
normalized to body weight as determined by NMR of male Nkx2.1-
Ntrk2-/- (n=6), Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6).
(E) Lean mass as determined by NMR of male Nkx2.1-Ntrk2-/- (n=6),
Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6). (F) Gonadal fat
weight of female Nkx2.1-Ntrk2-/- (n=6), Nkx2.1-Ntrk2+/- (n=8), and
wild type controls (n=10). (G) Body length for male Nkx2.1-Ntrk2-/-
(n=6), Nkx2.1-Ntrk2+/- (n=6), and wild type controls (n=6). (H) Body
length for female Nkx2.1-Ntrk2-/- (n=6), Nkx2.1-Ntrk2+/- (n=8), and
wild type controls (n=10). Weight curves are analyzed by two-way
ANOVA followed by Bonferroni post-hoc pairwise comparison
between Nkx2.1-Ntrk2-/- mice and wild type controls. All values are
mean ± SEM. Body composition and body length data are analyzed
by one-way ANOVA followed by Bonferroni post-hoc pairwise
comparison with the wild type controls. *p<0.05 compared to wild
type.
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Figure 4.5 continued
(A) Cumulative food intake of 5-6 week old, female Nkx2.1-Ntrk2-/- (n=6)
mice and wild type controls (n=6) on chow. (B) 5 day feed efficiency of
5-6 week old, female Nkx2.1-Ntrk2-/- (n=6) mice and wild type controls
(n=6). (C) Leptin-induced suppression of food intake in 8 week old male
Nkx2.1-Ntrk2-/- (n=5) mice and wild type controls (n=5). Baseline body
weight measurements for the days of saline injections were averaged
and used to calculate percent change. Leptin bar refers to the
measurement taken 72 hours after the first leptin injection. Recovery
bar refers to the measurement taken 48 hours after the last leptin
injection. (D) Leptin-induced reduction in body weight in 8 week old
male Nkx2.1-Ntrk2-/- (n=5) mice and wild type controls (n=5). Baseline
body weight measurements for the days of saline injections were
averaged and used to calculate percent change. Leptin bar refers to the
measurements 72 hours after the first leptin injection. Recovery bar
refers to the measurement taken 48 hours after the last leptin injection.
All values are mean ± SEM. Cumulative food intake is analyzed by two-
way ANOVA followed by Bonferroni post-hoc pairwise comparison
between Nkx2.1-Ntrk2-/- mice and wild type controls. Feed efficiency, %
change in food intake and body weight are analyzed by unpaired two-
tailed Student’s t-test *p<0.05 compared to wild type (and saline control
for C and D).
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Figure 4.6 continued
(A) Representative image of Phox2b-Ntrk2-/- mice and wild type
control littermates at P18. (B) Representative immunofluorescence
of Phox2b+ and TrkB+ cells in the NTS of control (top) and Phox2b-
Ntrk2-/- (bottom) mice. White arrows indicate representative cells
that are Phox2b+ and TrkB+. (C) TrkB protein levels in the NTS-
enriched lysates (top 2 blots) and the hypothalamus (bottom 2 blots)
of Phox2b-Ntrk2+/- (Het) and Cre- controls (WT). SHP2 protein levels
are shown as a loading control. (D) Blots are quantified using
ImageJ software, n=7 for each genotype. (E) Body weights of female
Phox2b-Ntrk2+/- (n=9) mice and wild type controls (n=17) on HFD.
(F) Gonadal fat weight of female Phox2b-Ntrk2+/- (n=9) mice and
wild type controls (n=11). (G) Body length for female Phox2b-
Ntrk2+/- (n=9) mice and wild type controls (n=11). All values are
mean ± SEM. Weight curves are analyzed by two-way ANOVA
followed by Bonferroni post-hoc pairwise comparison between
Phox2b-Ntrk2+/- mice and wild type controls. Body composition and
body length data are analyzed by unpaired two-tailed Student’s t -
test. *p<0.05 compared to wild type.
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Figure 4.7 Phox2b-Ntrk2+/- mice are hyperphagic on HFD. Cumulative
(A) and average daily (B) food intake of 12-13 week old, female Phox2b-
Ntrk2+/- (n=9) mice and wild type controls (n=10) on HFD. (C) Core
temperature of 13-14 week old, female Phox2b-Ntrk2+/- (n=5) mice and
wild type controls (n=7). (D) Ucp1 gene expression in the BAT of female
Phox2b-Ntrk2+/- (n=9) mice and wild type controls (n=9). Hprt1 gene is
used as a housekeeping gene. All values are mean ± SEM. Cumulative
food intake is analyzed by two-way ANOVA followed by Bonferroni
post-hoc pairwise comparison between Phox2b-Ntrk2+/- mice and wild
type controls. Average daily food intake and energy expenditure
measures are analyzed by unpaired two tailed Student’s t-test *p<0.05
compared to wild type. 96
Supplemental Figure 4.1 HPA axis activation and GTT are similar
between Nkx2.1-Ntrk2-/- mice and wild type controls on chow diet.
(A) HPA axis activation in 15 week old, male Nkx2.1-Ntrk2-/- (n=6)
mice and wild type controls (n=5) on chow diet. (B) Glucose
tolerance test of 13 week old, male Nkx2.1-Ntrk2-/- (n=11) mice and
wild type controls (n=14) on chow diet.
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Supplemental Figure 4.2 Phox2b-Ntrk2+/- males are similar in body
weight, adiposity and length compared to wild type controls on
HFD. (A) Body weights of male Phox2b-Ntrk2+/- (n=10) mice and
wild type controls (n=14) on HFD. (B) Gonadal fat weight of male
Phox2b-Ntrk2+/- (n=10) mice and wild type controls (n=10). (C) Body
length for male Phox2b-Ntrk2+/- (n=10) mice and wild type controls
(n=10). All values are mean ± SEM. Weight curves are analyzed by
two-way ANOVA followed by Bonferroni post-hoc pairwise
comparison between Phox2b-Ntrk2+/- mice and wild type controls.
Body composition and body length data are analyzed by unpaired
two-tailed Student’s t-test. *p<0.05 compared to wild type.
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Supplemental Figure 4.3 continued
(A) Body weights of male Phox2b-Ntrk2+/- (n=12) mice and wild type
controls (n=18) on chow. (B) Body weights of female Phox2b-
Ntrk2+/- (n=11) mice and wild type controls (n=11) on chow. (C)
Gonadal fat weight of male Phox2b-Ntrk2+/- (n=6) mice and wild type
controls (n=6). (D) Gonadal fat weight of female Phox2b-Ntrk2+/-
(n=5) mice and wild type controls (n=7). (E) Body length for male
Phox2b-Ntrk2+/- (n=6) mice and wild type controls (n=6). (F) Body
length for female Phox2b-Ntrk2+/- (n=5) mice and wild type controls
(n=7). Cumulative (G) and average daily (H) food intake of 12-13
week old, female Phox2b-Ntrk2+/- (n=5) mice and wild type controls
(n=7) on chow diet. All values are mean ± SEM. Weight curves and
cumulative food intake are analyzed by two-way ANOVA followed by
Bonferroni post-hoc pairwise comparison between Phox2b-Ntrk2+/-
mice and wild type controls. Body composition, body length, and
average daily food intake data are analyzed by unpaired two-tailed
Student’s t-test. *p<0.05 , #p<0.10 compared to wild type.
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Table 1 
HFD 
        
Fed 
(wk 13) 
Males 
Genotype Control 
(WT) 
Nkx2.1-Ntrk2+/- 
(Het) 
Nkx2.1-Ntrk2-/- 
(KO) 
  Blood glucose 
(mg/dl) 
125 ± 4 126 ± 9 145 ± 17 
  Serum insulin 
(ng/ml) 
6.4 ± 0.9 9. 5 ± 2.8 38.1 ± 14.0* 
  Serum leptin 
(ng/ml) 
24.4 ± 2.1 35.8 ± 4.9* 37.6 ± 1.8* 
  Serum T4 
(µg/dl) 
2.51 ± 0.19 N.D. 2.81 ± 0.15 
 
 Serum T3 
(ng/ml) 
0.78 ± 0.07 N.D. 0.82 ± 0.06 
Fasted  
(wk 15) 
Males 
Blood glucose 
(mg/dl) 
83 ± 7 71 ± 2 83 ± 7 
  Serum insulin 
(ng/ml) 
1.6 ± 0.2 1.4 ± 0.1 1.8 ± 0.1 
  Serum leptin 
(ng/ml) 
7.6 ± 1.9 17.3 ± 5.5 20.3 ± 3.5* 
Fed 
(wk 13) 
Females 
Blood glucose 
(mg/dl) 
113 ± 7 115 ± 5 163 ± 16* 
  Serum insulin 
(ng/ml) 
4.5 ± 1.2 8.2 ± 3.8 56.1 ± 10.7* 
  Serum leptin 
(ng/ml) 
32.7 ± 3.4 44.1 ± 8.6 78.4 ± 12.5* 
  Serum T4 
(µg/dl) 
3.73 ± 0.22 N.D. 4.35 ± 0.23 
 Serum T3 
(ng/ml) 
0.85 ± 0.14 N.D. 0.98 ± 0.06 
Fasted 
(wk 15) 
Females 
Blood glucose 
(mg/dl) 
71 ± 2 62 ± 3 99 ± 5* 
  Serum insulin 
(ng/ml) 
1.0 ± 0.1 1.4 ± 0.1 2.0 ± 0.1* 
  Serum leptin 
(ng/ml) 
15.3 ± 8.6 10.7 ± 3.2 46.2 ± 4.3* 
 
Table 1. Metabolic and neuroendocrine parameters of Nkx2.1-Ntrk2-/- mice on 
HFD. Random fed or overnight fasted Nkx2.1-Ntrk2-/-, Nkx2.1-Ntrk2+/- and wild 
type male and female mice are used in this study. Blood glucose, serum insulin 
and serum leptin measurements are taken on weeks 13 for fed and 15 for fasted 
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conditions. Serum T4 and T3 levels are measured on week 15. Blood glucose, 
serum insulin and serum leptin are analyzed by one-way ANOVA followed by 
Bonferroni post-hoc pairwise comparison between Nkx2.1-Ntrk2-/- mice and wild 
type controls. Serum T4 and T3 levels are analyzed by unpaired two tailed 
Student’s t-test. *p<0.05 compared to wild type.   
 
Table 2 
Chow 
        
Fed 
(wk 13) 
Males 
Genotype Control (WT) Nkx2.1-Ntrk2+/- 
(Het) 
Nkx2.1-Ntrk2-/- (KO) 
  Blood glucose 
(mg/dl) 
104 ± 5 101 ± 5 103 ± 4 
  Serum insulin 
(ng/ml) 
1.7 ± 0.1 1.7 ± 0.2 1.9 ± 0.4 
  Serum leptin 
(ng/ml) 
5.5 ± 0.5 4.7 ± 0.4 6.0 ± 0.9 
Fasted 
(wk 15) 
Males 
Blood glucose 
(mg/dl) 
76 ± 9 71 ± 7 58 ± 4 
  Serum insulin 
(ng/ml) 
1.1 ± 0.1 1.1 ± 0.1 1.1 ± 0.1 
  Serum leptin 
(ng/ml) 
2.2 ± 0.2 2.0 ± 0.2 2.2 ± 0.2 
Fed 
(wk 13) 
Females 
Blood glucose 
(mg/dl) 
110 ± 6 114 ± 4 129 ± 3* 
  Serum insulin 
(ng/ml) 
1.4 ± 0.1 1.6 ± 0.1 2.6 ± 0.4* 
  Serum leptin 
(ng/ml) 
4.9 ± 0.6 4.8 ± 0.4 20.5 ± 4.6* 
Fasted 
(wk 15) 
Females 
Blood glucose 
(mg/dl) 
73 ± 9 65 ± 4 56 ± 4 
  Serum insulin 
(ng/ml) 
1.2 ± 0.1 1.3 ± 0.1 1.4 ± 0.1 
  Serum leptin 
(ng/ml) 
3.2 ± 0.1 3.6 ± 0.4 6.7 ± 1.3* 
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Table 2. Metabolic and neuroendocrine parameters of Nkx2.1-Ntrk2-/- mice on 
chow diet. Random fed or overnight fasted Nkx2.1-Ntrk2-/-, Nkx2.1-Ntrk2+/- and 
wild type male and female mice are used in this study. Blood glucose, serum 
insulin and serum leptin measurements are taken on weeks 13 for fed and 15 for 
fasted conditions. All measurements are analyzed by one-way ANOVA followed by 
Bonferroni post-hoc pairwise comparison between Nkx2.1-Ntrk2-/- mice and wild 
type controls. *p<0.05 compared to wild type.   
Table 3       
HFD       
Fed (wk 13) 
Males 
  Control (WT) Phox2b-Ntrk2+/- (Het) 
  Blood glucose (mg/dl) 124 ± 4 119 ± 12 
  Serum insulin (ng/ml) 3.4 ± 0.4 3.4 ± 0.5 
Fasted (wk 
15) 
Males 
Blood glucose (mg/dl) 73 ± 2 74 ± 11 
  Serum insulin (ng/ml) 2.2 ± 0.1 2.1 ± 0.1 
Fed (wk 13) 
Females 
Blood glucose (mg/dl) 132 ± 7 130 ± 19 
  Serum insulin (ng/ml) 2.4 ± 0.1 2.5 ± 0.3 
Fasted (wk 
15) 
Females 
Blood glucose (mg/dl) 71 ± 6 76 ± 16 
  Serum insulin (ng/ml) 1.8 ± 0.1 1.9 ± 0.1 
Chow     
Fed (wk 13) 
Males 
  Control (WT) Phox2b-Ntrk2+/- (Het) 
  Blood glucose (mg/dl) 114 ± 8 108 ± 4 
  Serum insulin (ng/ml) 1.5 ± 0.1 1.9 ± 0.2 
Fasted (wk 
15) 
Males 
Blood glucose (mg/dl) 55 ± 2 75 ± 4* 
  Serum insulin (ng/ml) 1.0 ± 0.1 1.1 ± 0.1 
Fed (wk 13) 
Females 
Blood glucose (mg/dl) 104 ± 5 119 ± 5 
  Serum insulin (ng/ml) 1.5 ± 0.1 1.6 ± 0.2 
Fasted (wk 
15) 
Females 
Blood glucose (mg/dl) 71 ± 3 68 ± 4 
  Serum insulin (ng/ml) 0.9 ± 0.1 0.8 ± 0.1 
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Table 3. Metabolic and neuroendocrine parameters of Phox2b-Ntrk2+/- mice on 
HFD and chow diet. Random fed or overnight fasted Phox2b-Ntrk2+/- and wild type 
male and female mice are used in this study. Blood glucose and serum insulin 
measurements are taken on weeks 13 for fed and 15 for fasted conditions. All 
measurements are analyzed by unpaired two-tailed Student’s t-test. *p<0.05 
compared to wild type.  
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CHAPTER 5: Discussion 
 
PTP1B is a ubiquitously expressed protein tyrosine phosphatase demonstrated to play a 
paramount role in the central regulation of energy balance. Although the metabolic effects 
of PTP1B-deficiency are predominantly mediated through sensitized leptin signaling, 
whether PTP1B regulates additional pathways in the brain that contribute to the overall 
beneficial metabolic phenotype of PTP1B-deficiency remains unknown. In this 
dissertation, we examined the role of PTP1B in antagonizing the BDNF/TrkB signaling 
pathway in the brain and we further studied the importance of intact endogenous 
hypothalamic and hindbrain BDNF/TrkB signaling to central metabolic control. In Chapter 
2, we demonstrated that the TrkB receptor is a direct substrate for PTP1B, and that PTP1B 
overexpression impairs TrkB signaling while acute PTP1B inhibition augments TrkB 
signaling. Furthermore, Ptpn1-/- mouse brains show enhanced TrkB tyrosine 
phosphorylation and Ptpn1-/- mice are hypersensitive to BDNF-induced increase in core 
body temperature. These findings establish PTP1B as a novel, physiological regulator of 
central BDNF/TrkB signaling. Next, in Chapter 3, we showed that Ptpn1-/- mice exhibit 
enhanced adult, but not embryonic, hypothalamic neurogenesis. Ptpn1-/- mice have 
significantly more BrdU+ cells located in the median eminence of the hypothalamus 
surrounding the third ventricle, consistent with increased BDNF-sensitivity in Ptpn1-/- 
mice. Finally, in Chapter 4, we assessed whether intact endogenous hypothalamic and/or 
hindbrain BDNF/TrkB signaling is important in the central regulation of energy balance. 
Using hypothalamus- (Nkx2.1-Ntrk2-/-) or hindbrain- (Phox2b-Ntrk2-/-) specific TrkB-
deficient mice, we showed that Nkx2.1-Ntrk2-/- mice have significantly increased body 
weight and adiposity, and display glucose homeostasis impairments. Phox2b-Ntrk2-/- 
mice are perinatal lethal, but Phox2b-Ntrk2+/- heterozygous mice exhibit pronounced 
hyperphagia in the absence of a body weight phenotype. These data suggest that the 
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endogenous hypothalamic TrkB signaling is essential to the central metabolic control, and 
endogenous hindbrain TrkB signaling plays a role in modulating food intake. Taken 
together, this dissertation highlights the importance of endogenous hypothalamic and 
hindbrain BDNF/TrkB signaling in energy balance regulation and establishes PTP1B as a 
novel regulator of this signaling pathway.  
 
Anatomic localization of PTP1B’s metabolic effects on BDNF/TrkB signaling and 
accounting for developmental effects  
In Chapter 2, we established that PTP1B binds to and directly dephosphorylates Y706/707 
active site tyrosine residues in the tyrosine kinase domain of the TrkB receptor, thereby 
antagonizing the BDNF/TrkB signaling pathway. We also showed that mice with global 
PTP1B-deficiency have enhanced baseline TrkB phosphorylation in the hypothalamus, 
and that PTP1B-deficient mice have a heightened response to exogenous (i.c.v. 
administration into the lateral ventricle) BDNF-induced increase in core temperature. 
Since PTP1B is a ubiquitously expressed phosphatase and both BDNF and TrkB are 
broadly expressed in the brain, the exact site of action in the brain responsible for PTP1B’s 
regulation of metabolic effects of BDNF/TrkB signaling remains unclear.  
 
PVH is a hypothalamic nucleus where PTP1B potentially exerts its effects on BDNF-
induced increase in core temperature. Both BDNF and TrkB are expressed in the PVH 
(Yan, Radeke et al. 1997, Yan, Rosenfeld et al. 1997). Exogenous BDNF administration 
into the PVH results in enhanced thermogenesis through elevated core temperature, 
increased Ucp1 expression and activation of CRH/urocortin-expressing neurons (Wang, 
Bomberg et al. 2007, Toriya, Maekawa et al. 2010). A recently published study showed 
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that the BDNF+ neurons in the medial and posterior PVH stimulate adaptive 
thermogenesis by promoting the polysynaptic sympathetic outflow from the PVH through 
the spinal cord and stellate ganglion to the BAT (An, Liao et al. 2015). NTS in the hindbrain 
is another potential site for PTP1B’s regulation of BDNF-induced increase in core 
temperature. Both BDNF and TrkB are expressed in the NTS (Yan, Radeke et al. 1997, 
Yan, Rosenfeld et al. 1997). POMC-expressing neurons are found in the NTS of the 
hindbrain as well as the ARC of the hypothalamus. Pomc-Ptpn1-/- mice exhibit alterations 
in cold-induced thermogenesis, suggesting that PTP1B either in the ARC or the NTS 
controls the thermogenic response (De Jonghe, Hayes et al. 2011). Exogenous leptin or 
MTII (MCR agonist) administration into the hindbrain of Pomc-Ptpn1-/- mice increases 
core temperature, suggesting that hindbrain PTP1B plays a role in regulating body 
temperature (De Jonghe, Hayes et al. 2012). In order to determine whether PTP1B in 
these two sites is relevant to regulation of BDNF-induced thermogenic effects, we could 
cross Sim1-Cre or Phox2b-Cre mice to Ptpn1fl/fl mice to selectively delete PTP1B in the 
PVH or NTS, respectively. Alternatively, we could administer PTP1B inhibitors or AAV-
Cre to these sites prior to i.c.v. BDNF delivery to study the effects of acute PTP1B 
inhibition.  
 
Since Ptpn1-/- mice have an early loss of PTP1B during embryonic development, it is 
possible that alterations in the formation of the hypothalamic metabolic circuits account 
for the metabolic benefits of PTP1B-deficiency. Gross brain morphology and ARC-PVH 
projections in the hypothalamus appear normal in CNS PTP1B-deficient mice (Banno, 
Zimmer et al. 2010). However, both leptin and BDNF are trophic factors that profoundly 
affect the development of hypothalamic circuits. ob/ob mice show impaired ARC-PVH, 
ARC-DMH and ARC-LH projections, Bdnf klox/klox mice lacking long 3’UTR Bdnf mRNA 
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show impaired ARC-PVH NPY projections and ARC-DMH POMC projections (Bouret, 
Draper et al. 2004, Bouret, Gorski et al. 2008, Liao, Bouyer et al. 2015). Since both leptin 
and BDNF/TrkB signaling are negatively regulated by PTP1B, further research is required 
to explore whether loss of PTP1B at embryonic stage leads to changes in CNS feeding 
circuits development due to enhanced leptin and/or BDNF/TrkB signaling.  
 
Whether PTP1B-deficiency in adulthood also leads to sensitized BDNF/TrkB signaling is 
unknown. However, adult PTP1B-deficiency in the brain is reported to lead to metabolic 
improvements. Hypothalamic administration of PTP1B antisense oligonucleotides 
reduces body weight, adiposity and food intake in adult rats. It also leads to acutely 
improved leptin and insulin signaling (Picardi, Calegari et al. 2008). Furthermore, 
pharmacological inhibition of PTP1B improves central leptin-induced food intake 
suppression response in adult rats (Morrison, White et al. 2007). In order to determine the 
metabolic and signaling effects of adult PTP1B-deficiency, we could use AAV-Cre delivery 
to Ptpn1fl/fl mice. This way, we can target PTP1B-deficiency to any hypothalamic or extra-
hypothalamic site of interest and at any age, thereby having both spatial and temporal 
control over PTP1B-deficiency. Alternatively, we could use inducible Cre mouse lines 
crossed to Ptpn1fl/fl mice and compound Ptpn1fl/fl:Ntrk2fl/fl mice to generate PTP1B and 
PTP1B:TrkB mutants. This will allow us to have tight spatial and temporal control over 
both PTP1B- and TrkB-deficiency and will also help us determine whether BDNF/TrkB 
signaling is an important contributor to the metabolic phenotype of PTP1B-deficiency.    
 
PTP1B’s regulation of BDNF/TrkB signaling at the cellular level and leptin-
dependence 
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In Chapter 2, we showed that acute pretreatment with a PTP1B-specific inhibitor increases 
BDNF-induced neurite outgrowth in SH-SY5Y-TrkB human neuroblastoma cells. 
Furthermore, in Chapter 3, we reported that Ptpn1-/- mice have significantly more BrdU+ 
cells in the hypothalamus, suggesting enhanced adult hypothalamic neurogenesis. 
Whether these observations of increased neurite outgrowth and increased number of 
newly born hypothalamic neurons are BDNF/TrkB-dependent will require further 
investigation. In the future, we could test this pharmacologically through the use of TrkB 
inhibitors/antagonists applied to the cell culture medium or i.c.v./intraparenchymal delivery 
into the Ptpn1-/- brain region(s) of interest (Spaeth, Kanoski et al. 2012).   
 
The exact cellular and circuit-level changes due to sensitized BDNF/TrkB signaling in 
PTP1B-deficiency remain unclear. Leptin induces BDNF gene expression and BDNF 
protein content in the VMH of the hypothalamus and the DVC of the hindbrain (Bariohay, 
Lebrun et al. 2005, Liao, An et al. 2012). Previous studies reported BDNF/TrkB signaling 
to be downstream of MC4R signaling. MCR agonist MTII induces BDNF gene expression 
in the VMH and the DVC. In these two sites, BDNF reverses the effects of MC4R 
antagonists, and TrkB inhibitors block the effects of MC4R agonists (Xu, Goulding et al. 
2003, Bariohay, Roux et al. 2009). Within the VMH, leptin receptor and BDNF do not co-
localize, suggesting that leptin’s effects on BDNF involve hypothalamic network activity. A 
previous study reported that leptin promotes the translation of dendritically localized BDNF 
mRNA with 3’ long UTR, which is necessary to convey leptin’s signal to activate 
hypothalamic neurons and suppress food intake (Liao, An et al. 2012). It is possible that 
enhanced leptin signaling in the absence of PTP1B promotes neural activity which 
increases Ca+2 influx and subsequently promotes BDNF transcription and translation at 
the dendrites through voltage-gated Ca+2 channels and/or N-methyl-d-aspartate (NMDA) 
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glutamate receptors. In fact, glutamate enhances BDNF gene expression and BDNF 
protein content in the hypothalamic neurons via NMDAR activation, and GABA diminishes 
glutamate-stimulated BDNF expression in the hypothalamus (Marmigere, Rage et al. 
2003). BDNF transcription, translation and eventual release into the synaptic cleft may 
consequently result in the formation and/or strengthening of distinct synapses contributing 
to the plasticity in the hypothalamic feeding circuits.  
 
There is very little overlap between TrkB+ cells and POMC+ or NPY+ cells in the ARC 
(Xu, Goulding et al. 2003, Liao, Bouyer et al. 2015). Thus, it is improbable that enhanced 
BDNF/TrkB signaling in PTP1B-deficiency directly modulates POMC or NPY expression 
in the ARC as a means of plasticity. The effects are more likely through indirect changes 
in the hypothalamic circuitry. One possible mechanism is the alteration/remodeling of 
GABAergic transmission. BDNF decreases the frequency of miniature inhibitory post-
synaptic potentials (mIPSCs) in the PVH by reducing the surface expression of the post-
synaptic GABAA receptors (Hewitt and Bains 2006). In the PVH, a subset of NPY/AGRP+ 
neurons send GABAergic collaterals to inhibit the POMC neurons in the ARC (Cowley, 
Smart et al. 2001). BDNF’s metabolic effects may partly be through disinhibition of POMC 
neurons in the ARC. This hypothesis may be assessed by electrophysiological recordings 
of NPY/AGRP+ neurons in the PVH and POMC+ neurons in the ARC upon BDNF 
stimulation in the PVH.     
 
Metabolic phenotype of Nkx2.1-Ntrk2-/- and Phox2b-Ntrk2+/- mice explained at the 
cellular and systems level 
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In Chapter 4, we used Nkx2.1- and Phox2b-Cre mouse lines to spatially restrict 
endogenous TrkB-deficiency to the hypothalamus or to the hindbrain. However, which 
nuclei within these two brain regions are responsible for the observed metabolic 
phenotypes of TrkB-deficiency remains unknown.  
 
In Chapter 4, we demonstrated that Nkx2.1-Ntrk2-/- mice have significantly increased 
body weight and adiposity on both HFD and chow diet. On HFD, the overall body weight 
phenotype is initially driven by decreased energy expenditure through lower core 
temperature and reduced locomotor activity while food intake is similar between Nkx2.1-
Ntrk2-/- mice and wild type controls. On chow diet, Nkx2.1-Ntrk2-/- mice show increased 
food intake and feed efficiency, suggesting that the increased body weight is a result of 
changes in both food intake and energy expenditure. Nkx2.1-Ntrk2-/- mice also show 
impairments in glucose homeostasis which are most likely secondary to the increased 
body weight.  
 
Nkx2.1 is a homeobox transcription factor whose expression starts at E9.5. Nkx2.1 is 
expressed in both the progenitor cells and the post-mitotic neurons, suggesting that it is 
important for both the development and maintenance of neurons. Nkx2.1 is essential for 
the development of GABAergic and cholinergic interneurons that migrate from the medial 
ganglionic eminence (MGE) to subcortical brain regions to form the different subtypes of 
interneurons (Xu, Tam et al. 2008). Fate-mapping studies show that in the hypothalamus, 
Nkx2.1+ cells give rise to a sub-population of NPY+, POMC+, GABAergic, and 
dopaminergic neurons (Yee, Wang et al. 2009). In the ARC, there is very little co-
localization between TrkB+ cells and NPY+, POMC+, or Rip-Cre GABAergic cells (a 
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subtype of neurons that synapse onto the PVH and then project to the NTS), suggesting 
that TrkB+ cells in the ARC are likely a distinct subtype which will require further 
investigation (Liao, Bouyer et al. 2015). Nkx2.1 is also expressed in the posterior pituitary, 
thyroid, esophagus and the lungs, but there is no evidence that TrkB is expressed in these 
peripheral regions (Ring and Zeltser 2010).  
 
Nkx2.1 is broadly expressed in the hypothalamus, including the PVH, VMH, DMH, LH and 
ARC (Ring and Zeltser 2010). Of these sites, the metabolic role of BDNF/TrkB signaling 
in the VMH and the PVH is well characterized although all of these nuclei express the 
TrkB receptor. Exogenous BDNF administration into both VMH and PVH suppresses food 
intake on both chow diet and HFD (Wang, Bomberg et al. 2007, Wang, Bomberg et al. 
2007, Wang, Godar et al. 2010, Godar, Dai et al. 2011). BDNF-deficiency through AAV-
Cre administration into the VMH/DMH results in hyperphagia (Unger, Calderon et al. 
2007). BDNF-deficiency developmentally (Sim1-Cre) or in adulthood through AAV-Cre 
administration into the PVH also results in hyperphagia (An, Liao et al. 2015). Taken 
together, increased food intake observed in chow-fed Nkx2.1-Ntrk2-/- mice may potentially 
be due to TrkB-deficiency in the VMH and/or the PVH. Exogenous BDNF administration 
into both VMH and PVH increases energy expenditure on chow diet through increased 
spontaneous physical activity and increased resting metabolic rate/enhanced 
thermogenesis, respectively (Wang, Bomberg et al. 2007, Wang, Bomberg et al. 2010). 
BDNF-deficiency through AAV-Cre administration into the VMH/DMH does not affect the 
energy expenditure parameters (Unger, Calderon et al. 2007). Interestingly, BDNF-
deficiency either developmentally (Sim1-Cre) or in adulthood through AAV-Cre 
administration into the PVH decreases energy expenditure, reduces physical activity, and 
impairs thermogenic response (observed through changes in BAT weight, BAT 
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morphology, thermogenic gene expression, and response to a cold challenge) (An, Liao 
et al. 2015). This implies that the reduced physical activity and core temperature 
phenotype along with the altered WAT/BAT gene profiles of the HFD-fed Nkx2.1-Ntrk2-/- 
mice may likely be due to TrkB-deficiency in the PVH. BDNF in both VMH and PVH is 
reported to regulate glucose homeostasis. Exogenous BDNF administration into the VMH 
attenuates hyperglycemia (Meek, Wisse et al. 2013). Mice lacking BDNF in the VMH or 
PVH have hyperglycemia and hyperinsulinemia (Unger, Calderon et al. 2007, An, Liao et 
al. 2015). BDNF disinhibits VMH Sf-1+ neurons by reducing the GABAergic tone (Jo 
2012). It is plausible that disinhibition of VMH Sf-1+ neurons by BDNF increases the 
excitatory projections from VMH to PVH which subsequently regulate liver glucose 
metabolism (Jo and Chua 2013). Thus, the impaired glucose homeostasis observed in 
Nkx2.1-Ntrk2-/- may be secondary to weight gain, but could conceivably be due to 
deficiency of TrkB in the VMH and/or the PVH.  
 
In Chapter 4, we reported that Phox2b-Ntrk2-/- mice are perinatal lethal, likely due to the 
vital role of the hindbrain TrkB neurons implicated in the development of visceral motor 
neurons regulating cardiovascular, respiratory, and digestive functions (Pattyn, Morin et 
al. 1997, Pattyn, Morin et al. 1999, Pattyn, Hirsch et al. 2000). Phox2b-Ntrk2+/- mice are 
viable and they are hyperphagic on both HFD and chow diet, without showing significant 
differences in body weight.  
 
Phox2b is a homeobox gene whose expression starts at E9.5. Phox2b is expressed in 
both the CNS and the PNS. Phox2b is essential for the development of autonomic neural 
circuits including the sympathetic, parasympathetic and the enteric nervous systems 
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(Pattyn, Morin et al. 1999). In the hindbrain, Phox2b is expressed in the NTS, and the area 
postrema (AP), and is required for the generation of branchial (trigeminal (CNV) and facial 
(CNVII) nerves) and visceral (dorsal motor nucleus of the vagus (CNX) nerve) motor 
neurons (Pattyn, Morin et al. 1997, Pattyn, Hirsch et al. 2000). Fate-mapping studies show 
that Phox2b+ cells give rise to cholinergic pre-ganglionic parasympathetic neurons and 
are also important in noradrenergic cell type differentiation in the sympathetic nervous 
system (Pattyn, Morin et al. 1999, Rossi, Balthasar et al. 2011).    
 
Phox2b is expressed in the NTS of the hindbrain as well as the nodose ganglia. 
Importantly, it is not expressed in the peripheral sympathetic and parasympathetic ganglia, 
or the enteric nervous system (Scott, Williams et al. 2011). TrkB is expressed in the NTS 
where exogenous BDNF administration suppresses food intake (Spaeth, Kanoski et al. 
2012). It is also expressed in the nodose ganglion where TrkB levels change with the 
consumed diet and the energy status (Zeeni, Chaumontet et al. 2009). Since Phox2b-
Ntrk2+/- mice are hyperphagic without a significant difference in body weight, increase in 
food intake may be off-set with increase in energy expenditure, similar to Phox2b-LepRb-
/- mice (Scott, Williams et al. 2011). In Chapter 4, we concluded that hindbrain TrkB-
heterozygosity is sufficient to influence feeding but not the body weight. In the future, in 
order to avoid the developmental impairments observed in Phox2b-Ntrk2-/- mice, we could 
administer AAV-Cre into the NTS to achieve better hindbrain TrkB deletion efficiency in a 
spatially and temporally controlled manner. Nodose ganglia provide vagal afferent fibers 
from the gastrointestinal tract to the NTS, mediating food intake suppression and satiation. 
BDNF/TrkB signaling is essential for the development and the survival of the nodose 
ganglia (Erickson, Conover et al. 1996). It is possible that Phox2b-Ntrk2+/- mice have 
reduced number of nodose ganglia, and reduced endogenous BDNF/TrkB signaling in the 
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nodose ganglia of Phox2b-Ntrk2+/- mice alters the excitatory synaptic transmission to the 
NTS. Diminished satiation signals from the nodose ganglia to the NTS subsequently lead 
to hyperphagia in Phox2b-Ntrk2+/- mice (Wan, Browning et al. 2008, Campos, Shiina et 
al. 2014). This hypothesis could be examined by surgical dissection of the nodose ganglia 
and also performing electrophysiological recordings in the nodose ganglia and the NTS.  
 
Neural connectivity between the NTS of the hindbrain and more rostral hypothalamic 
nuclei including the LH, ARC and PVH contributes to the central metabolic control 
significantly (reviewed in (Grill and Hayes 2012)). Thus, the metabolic phenotype of 
hypothalamic and/or hindbrain TrkB-deficient mice may partly be due to the alterations in 
these circuitries. In the LH, Orexin+ neurons send projections to both the NTS and the 
vagal afferent synaptic terminals mediating the gastrointestinal signals. These projections 
have a functional role in feeding stimulation (Zheng, Patterson et al. 2005). In the LH, 
TrkB+ cells do not co-localize with the Orexin+ cells, suggesting that this transmission 
may be unaltered in Nkx2.1-Ntrk2-/- mice (Xu, Goulding et al. 2003). POMC+ neurons 
send direct projections from the ARC to the NTS that are reported to have a functional 
role in feeding inhibition (Zheng, Patterson et al. 2010). There is very little co-localization 
(~15%) between the TrkB+ cells and POMC+ cells in the ARC (Liao, Bouyer et al. 2015), 
implying that ARC-NTS transmission also may not be impaired in Nkx2.1-Ntrk2-/- mice. 
POMC+ neurons in the ARC also project to the NTS indirectly through the PVH. 
Oxytocinergic neurons in the PVH send excitatory projections to the NTS and also the 
vagal afferents, thereby enhancing glutamatergic transmission to the NTS (Rinaman 
1998). Whether TrkB+ cells co-localize with Oxytocin+ cells in the PVH remains unknown; 
however, given the role of BDNF/TrkB signaling in the PVH, it is possible that the ARC-
PVH-NTS transmission is altered in Nkx2.1-Ntrk2-/- mice. These hypotheses could be 
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tested through retrograde tracing experiments and performing electrophysiological 
recordings.  
 
PTPs and regulation of Trk family members 
All members of the Trk receptor family have the conserved tyrosine kinase sequence in 
their active site tyrosine kinase domain which PTP1B targets ((E/D)-pY-pY-(R/K) 
sequence (Espanel, Huguenin-Reggiani et al. 2002)), raising the intriguing possibility that 
the other Trk family members may also be PTP1B substrates. The Trk receptor family 
consists of three receptor tyrosine kinases, TrkA, TrkB and TrkC, each of which can be 
activated by one or more of the neurotrophins - NGF for TrkA, BDNF and NT4 for TrkB, 
and NT3 for TrkC (reviewed in (Reichardt 2006)). Trk receptors have also been implicated 
in many forms of cancer including neuroblastoma (reviewed in (Thiele, Li et al. 2009)). 
TrkA is expressed at high levels in neuroblastomas with more favorable outcomes, 
whereas TrkB and BDNF are highly expressed in more aggressive neuroblastomas with 
poor prognosis (reviewed in (Brodeur, Minturn et al. 2009)). It will be useful to assess 
whether PTP1B can be used as a Trk-selective inhibitor to treat tumors with activated Trk 
expression, and whether PTP1B has similar selectivity for dephosphorylating TrkB 
compared to other Trk family members.  
 
Interestingly, TrkB signaling is also known to be modulated by other protein tyrosine 
phosphatases (Rusanescu, Yang et al. 2005, Yang, Massa et al. 2006, Ambjorn, Dubreuil 
et al. 2013, Gatto, Dudanova et al. 2013). Ptpn12 antagonizes TrkB signaling through 
dephosphorylation of the Y816 residue of the TrkB receptor (Ambjorn, Dubreuil et al. 
2013). LAR is a positive regulator of TrkB signaling by activating Src protein kinases which 
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transactivates TrkB receptor on the Y515 residue (Yang, Massa et al. 2006). SHP2 is a 
negative regulator of TrkB signaling acting through Ras inhibition (Rusanescu, Yang et al. 
2005). How PTP1B interacts with these proteins remains unknown. 
 
Overall, this dissertation definitively establishes the hypothalamus and the hindbrain as 
important brain regions in endogenous BDNF/TrkB signaling and the central regulation of 
energy balance. Furthermore, it highlights a newly discovered role for PTP1B as a 
physiological regulator of central BDNF/TrkB signaling. This finding is important not only 
in the context of metabolism, but may have broader implications for TrkB regulation in the 
context of neural development, neurogenesis, and cancer. Discovering a previously 
unidentified substrate for PTP1B is also pioneering as it will enhance our understanding 
of PTP1B’s effects in metabolism and thus has substantial implications for the potential 
use of PTP1B inhibitors as a therapy for obesity.    
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